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ABSTRACT
Corticosterone-Induced Potentiation of Cocaine Seeking: A
Potential Role For Organic Cation Transporter 3

Evan N Graf
Marquette University, 2012

While it is known that stress plays a role in the relapse of cocaine-seeking
behavior, recent studies demonstrate that stress may be acting as a “stage setter”
rather than directly triggering further cocaine use. This model suggests stimuli that
do not normally evoke relapse under stress-free conditions may result in drug
seeking when the exposure occurs under stressful conditions. In this study, we
examined the corticosterone-dependent potentiation of cocaine-induced
reinstatement by a stressor, electric footshock (EFS), in rats following cocaine selfadministration and extinction. We found that in rats with a history of drug exposure
under low intake conditions, footshock alone did not reinstate cocaine seeking, but
did result in a potentiation of reinstatement in response to a subthreshold dose of
cocaine (2.5 mg/kg, ip.). This effect was abolished in adrenalectomized rats and
reproduced in intact animals receiving a physiologically relevant dose of
corticosterone (2.0 mg/kg, ip.). Administration of the glucocorticoid receptor (GR)
antagonist RU-486 did not block these effects, suggesting a rapid, non-GR mediated
mechanism. In order to determine the site of action, we performed in vivo
microdialysis to measure dopamine levels in the nucleus accumbens (NAc) and
found that, similar to its actions on cocaine-seeking behavior, corticosterone
potentiated cocaine-induced increases in dopamine. In support of this evidence,
direct administration of corticosterone into the NAc or prefrontal cortex (PFC)
potentiated reinstatement to a subthreshold dose of cocaine, an effect that was
blocked with pretreatment of the dopamine antagonist, fluphenazine.
Through immunoflourescence studies, we have shown the presence of a high
capacity, corticosterone sensitive, monoamine transporter, organic cation
transporter 3 (OCT3), located in the NAc adjacent to tyrosine hydroxylase terminals,
suggesting a potential interaction with dopamine clearance. Based on this, we
hypothesize the mechanism involves corticosterone inhibition of OCT3-mediated
dopamine clearance. In support of this mechanism, pretreatment of rats with
normetanephrine, a non-glucocorticoid OCT3 inhibitor mimics the effect of
corticosterone on reinstatement. These results suggest a novel mechanism through
which stress may modulate dopaminergic signaling and promote drug-seeking
behavior.
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I. BACKGROUND
Introduction
Drug addiction is a chronically relapsing disorder that is characterized by
three traits: (1) Compulsion to seek and consume the drug, (2) an inability to
control or limit intake of the drug, and (3) the presence of a negative emotional
state, including anxiety and irritability, when the drug is not available (Koob and Le
Moal 1997). This is distinct from occasional, recreational use of a drug, which,
although it can still be detrimental to an individual’s health, is not characterized as
addiction. Drug abuse and addiction results in over $160 billion worth of direct and
indirect costs, including medical bills and societal issues (Bouchery, Harwood et al.
2001). This makes this disease a concern for a great number of individuals in our
society and with no current, effective treatment strategy in place, it is the subject of
intense research. Until we are able to gain a greater understanding of the condition
and the neural mechanisms involved in the establishment, it is unlikely we will be
able to effectively treat the individuals in need. It is the goal of this work to learn
more about this disease and begin to explore potential new methods of treatment.
Cocaine
Cocaine is one of the most abused illicit drugs in America and is responsible
for more emergency room visits than any other drug. Cocaine is an alkaloidal agent
that was originally isolated from the leaves of the Erythroxylon coca bush primarily
found in South America (Grabowski 1984). As one of the oldest known psycho
stimulants, cocaine has been used for hundreds of years, originally coveted for its
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ability to increase energy levels and decrease hunger (Kennedy 1985). Cocaine was
primarily ingested by chewing on the coca leaf until it was isolated in the 1800s
when there was an increase in use, including being added as an ingredient in many
beverages as well as medicines.
Today, cocaine is labeled a Schedule II drug, meaning it has a high potential
for abuse, but may still be prescribed for certain medical issues by physicians.
Cocaine is a psychomotor stimulant that acts as an indirect sympathomimetic,
similar to amphetamine. Psychomotor stimulants result in increases in arousal,
alertness and overall motor activity and indirect sympathomimetics mimic the
effects of sympathetic nervous system transmitters such as norepinephrine and
dopamine (Koob and Le Moal 2006). Cocaine has also been used in medical
situations as a local anesthetic during minor surgical procedures. Recently,
however, other anesthetic drugs have largely taken its place.
Cocaine is most commonly abused in two different forms. As a hydrochloride
salt it can be injected or snorted as a fine white powder. The freebase form,
commonly referred to as “crack”, is created by precipitating cocaine hydrochloride
into an alkaline solution and can be heated and smoked (Kennedy 1985). Cocaine
hydrochloride is absorbed through mucous membranes or injected directly into the
body. When administered nasally, peak concentrations in the plasma can be seen
after approximately 60 minutes (Javaid, Fischman et al. 1978). When cocaine is
transformed into freebase or crack and smoked, blood levels of the drug can reach
levels seen following intravenous injection, the fastest route of entry, with peak
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plasma concentrations seen within minutes (Jatlow 1987; Cook and Jeffcoat 1990).
While the primary method of administration among users is snorting, all routes of
administration can lead to serious health problems, including cardiovascular
emergencies and seizure that can result in death.
Neurobiological Mechanisms of Cocaine Action
The rewarding properties of cocaine are a result of an increase in
extracellular monoamine concentrations that occur within the brain (Taylor and Ho
1978; Ritz, Cone et al. 1990). In particular, cocaine blocks the reuptake of
norepinephrine, dopamine and serotonin in the brain through inhibition of the
respective transporters, with the greatest ability to block the reuptake of serotonin
and the least being norepinephrine (Glowinski and Axelrod 1965; Iversen 1973;
Rothman, Baumann et al. 2001). However, the actions on extracellular dopamine
concentrations appear to be primarily responsible for most behavioral,
physiological, and addicting actions of cocaine and it is the neurotransmitter
examined in these studies.
Cocaine elevates dopamine levels through inhibition of a sodium and energy
dependent transporter, the dopamine transporter (DAT)(Cao, Shamoo et al. 1990;
Jones, Garris et al. 1995). Recent evidence suggests that the binding sites for
cocaine and dopamine on DAT may overlap (Beuming, Kniazeff et al. 2008). This
creates greater difficulty in treatment, as an antagonist used to block the binding
site of cocaine would also prevent dopamine itself from interacting with its
transporter. Other drugs of abuse, such as amphetamine, opiates and ethanol, also
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exert their effects by altering dopamine levels, but through slightly different
mechanisms. The common action of these drugs led to the dopamine hypothesis of
drug abuse. This was hypothesized by Di Chiara and Imperato when they
discovered an increase in dopamine levels in the nucleus accumbens (NAc) and
dorsal caudate nucleus, both of which are terminal dopaminergic areas, using brain
dialysis in freely moving rats (Di Chiara and Imperato 1988). In addition, positron
emission tomography (PET) studies have shown radiolabeled cocaine distributed in
the brain in areas that also contained dopamine, such as the striatum (Fowler,
Volkow et al. 1989). Based on this work in these studies it was concluded that drugs
readily abused by humans all produce an increase in dopamine concentrations,
particularly in the NAc, which has led researchers to focus on this region and
projections to and from the NAc.
Mesolimbic Dopamine System
Extensive studies using animal models of cocaine use indicate that the
rewarding properties of psychostimulants, such as cocaine, are accompanied by
increased neuronal activity in the mesolimbic dopamine system (Wise and Rompre
1989). The mesolimbic dopamine system is comprised of dopaminergic cell bodies
in the ventral tegmental area (VTA) that project to the medial and orbital regions of
the prefrontal cortex (PFC), nucleus accumbens (NAc), amygdala and the bed
nucleus of the stria terminalis (BNST)(Wise 2004; Pierce and Kumaresan 2006). It
has also been shown that some acute stressors, including exposure to footshock,
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may also have effects on the mesolimbic dopamine system (Cabib and PuglisiAllegra 1996).
Role of Dopamine in Motivated Behavior
Dopamine has long been demonstrated to be involved in movement and
motor function (Campanella, Roy et al. 1987). While this role of dopamine in motor
function is known, studies have shown that dopamine antagonists exert other
functions on behavior at concentrations that do not alter movement or action.
Blocking the actions of dopamine has been demonstrated to attenuate reward and
motivational behavior. When treated with dopamine antagonists, rats exhibit a
state of anhedonia including a reduced effort to receive either food or water, while
overall motor function remained intact (Wise, Spindler et al. 1978; Gerber, Sing et al.
1981). Dopamine antagonists have also been shown to attenuate brain selfstimulation, a model of reward seeking, while not altering motor abilities (Fouriezos
and Wise 1976; Fouriezos, Hansson et al. 1978). Additionally, treatment of rats with
dopamine antagonists blocks the rewarding effects of drugs, such as cocaine (De Wit
and Wise 1977). These results strongly implicate dopaminergic activity in rewarddependent learning and suggest that dopamine directly mediates the motivational
processes underlying reinforcement. However, this does not mean that dopamine is
the only reward transmitter in the brain. Dopamine antagonists and lesions to the
dopamine systems do not completely eliminate rewarding effects of brain
stimulation or drugs such as apomorphine (Simon, Stinus et al. 1979; Roberts and
Vickers 1988). While dopamine may not be the only reward transmitter in the
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brain, it does appear to play a critical role in the rewarding aspects of many hedonic
stimuli, suggesting it may be an integral component of drug use.
Dopamine also appears to play a role in incentive motivation (Stewart, de
Wit et al. 1984). Incentive motivation refers to the motivational aspects an
otherwise neutral stimulus has acquired after prior association with a reward,
causing the stimulus to drive behavior. If the dopamine system is not functioning
properly, reward no longer places incentive-motivational value on otherwise
predictable stimuli (Wise and Schwartz 1981; Spyraki, Fibiger et al. 1982; Stewart,
de Wit et al. 1984; Spyraki, Nomikos et al. 1987). Once the relationship between
stimulus and reward is established, incentive-motivational stimuli appear to be able
to elicit behavioral responses even if the dopamine system is blocked, suggesting
dopamine is required at the period involved in the formation of this relationship
(Gerber, Sing et al. 1981; Wise and Colle 1984; McFarland and Ettenberg 1995;
Dickinson, Smith et al. 2000). Over time, however, if tested under the condition of
dopamine antagonism, the association will slowly diminish and become unlearned
(Franklin and McCoy 1979; Dickinson, Smith et al. 2000). This suggests that
dopamine is important both in reinforcement effects of a reward as well as the
incentive motivation prior to earning a reward. The importance of dopamine in
incentive motivation relies on the presence of dopamine at the time the reward is
administered, thus causing reward related learning (Waelti, Dickinson et al. 2001).
As dopamine appears to be such a key neurotransmitter in motivated
behavior, further studies were performed in order better understand its role.
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Studies were performed in which recordings were taken from dopamine neurons in
response to exposure to appetitive or aversive stimuli. These studies showed that
appetitive, but not aversive stimuli resulted in a phasic activation of dopamine
neurons, in most cases (Schultz 1986; Mirenowicz and Schultz 1996). Also of
interest was the finding that after repeated pairings of visual or auditory cues with
the presentation of a reward, activation of the dopaminergic neurons switched from
just after onset of reward to the time the cue was received (Apicella, Scarnati et al.
1992; Ljungberg, Apicella et al. 1992). This suggests that the animal has learned to
associate the cue with the reward and the cue is now responsible for the activation
of dopamine neurons, not the reward itself. Furthermore, if the reward is not
delivered following the cue, dopamine neurons decrease their firing rates below
basal firing rates at the exact time the reward was expected. This suggests that
dopaminergic activity is also involved in the timing of reward delivery (Hollerman,
Tremblay et al. 1998).
Dopamine Response to Aversive Stimuli
Another layer of complexity involved in the actions of dopamine is whether
or not it only signals aspects of reward or if dopamine can be a signal regardless of
hedonic value. This is a topic of debate as there are data showing that aversive
stimuli inhibit midbrain dopamine neurons (Ungless, Magill et al. 2004) while
others have shown both the inhibition and activation of these neurons (Chiodo,
Antelman et al. 1980; Mantz, Thierry et al. 1989). Recent evidence, however,
suggests that these findings may be explained by the presence of two distinct groups
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of VTA dopamine neurons (Brischoux, Chakraborty et al. 2009; Matsumoto and
Hikosaka 2009). One group of dopamine neurons responds to stimuli that are
rewarding or associated with reward, while the other group responds to any salient
stimulus (Matsumoto and Hikosaka 2009). It has been suggested that the function
of the dopamine neurons that respond to rewarding stimuli would be useful in
learning to approach rewards while avoiding aversive situations, but the function of
the neurons responsive to any salient stimuli remains unclear (Matsumoto and
Hikosaka 2009). These data suggesting differential responding from different
dopaminergic regions are in agreement with data demonstrating that the same
pharmacological manipulations that will result in feeding when administered to the
medial NAc shell, will stimulate defensive behaviors when administered more
caudally (Reynolds and Berridge 2002; Reynolds and Berridge 2003). Together
these data suggest a complex role of dopaminergic activity within the mesolimbic
dopamine system. While dopamine does appear to play a central role in reward and
reward related behaviors, it may be that dopamine is involved in many other
processes as well, such as aversion, which will require further research to fully
understand.
Differential role of Nucleus Accumbens core and shell
The NAc has long been considered to be a critical site for the locomotor and
reinforcing actions of drugs of abuse (Wise and Bozarth 1987; Robbins and Everitt
1996), but there is some debate over the role of the two subdivisions, the nucleus
accumbens core and shell (Di Chiara 2002; Ito, Robbins et al. 2004). The NAc shell
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receives input from the basolateral amygdala and ventral subiculum and the core
receives input from the basolateral amygdala and parahippocampal regions
(Groenewegen, Wright et al. 1999; French and Totterdell 2003). It has been
observed that drugs of abuse (Pontieri, Tanda et al. 1995; Cadoni and Di Chiara
1999), as well as other nondrug rewards, stimulate dopamine transmission
predominantly in the shell of the NAc, opposed to the core (Bassareo and Di Chiara
1999). Based on these observations it has been postulated that dopamine in the
NAc shell is involved in strengthening drug associations and matching the reward
stimulus with the resulting biological outcome. In contrast to this it has been
suggested that dopamine in the NAc core is involved the motivation to seek a
reward and converting these motivations to action (Di Chiara 1999).
Intracerebral self-administration studies support the hypothesis that the NAc
shell is the main site involved in the reinforcing actions of psychostimulants
(McBride, Murphy et al. 1999). This is demonstrated by studies showing that
amphetamine, as well as other drugs, are readily self-administered into the shell,
but not other brain regions (Hoebel, Monaco et al. 1983). Additionally, some studies
have been able to show self-administration of cocaine directly into the shell of the
NAc (Carlezon, Devine et al. 1995; McKinzie, Rodd-Henricks et al. 1999). This effect
is of some debate, however, as these findings are not always seen (Goeders and
Smith 1993). The role of the shell in the reinforcing actions of drugs of abuse is
further demonstrated by studies showing dopamine D1 and D2 receptor agonists will
be self-administered into the shell, but not the core, when co-infused and will also
cause reinstatement of cocaine seeking when administered to the shell (Ikemoto,
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Glazier et al. 1997; Schmidt, Anderson et al. 2006). Additionally, cocaine and other
psychostimulants have been shown to elevate dopamine levels in the NAc shell
when measured through in vivo microdialysis (Pontieri, Tanda et al. 1995).
These studies demonstrate that the subdivisions of the NAc may play
different roles in regulating drug self-administration as well as reinstatement.
While the data presented here suggest that the shell is involved in the reinforcing
effects of drug and the core to be involved in the motivational and action circuitry,
this topic is still the subject of much debate. For the purpose of the studies
presented here, this topic is largely left unexplored. Future studies may involve
examining the role of the NAc subdivisions and how they may play different roles in
the findings presented below.
Role of Dopamine in Drug Use
The importance of dopamine and the dopaminergic pathway as it relates to
drugs of abuse was confirmed following evidence that selective lesions to the
mesolimbic dopamine system prevent the reinforcing of effects of psychostimulants
such as cocaine (McGregor and Roberts 1993). Interestingly, activation of this
system does not appear to be necessary for the reinforcing effects of all drugs with
abuse potential (Koob 1992), as studies have shown that robust morphine-induced
reward, as measured by conditioned place preference, can still be seen in dopaminedeficient mice (Hnasko, Sotak et al. 2005), suggesting that this system is especially
important in regards to psychostimulants.
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Within the mesolimbic dopamine system, the nucleus accumbens and the
prefrontal cortex have been specifically targeted in the work presented here, with
the majority of the work being focused in the nucleus accumbens. There have been
extensive studies using intracranial self-administration demonstrating the
importance of these regions. In these studies, opioids, phencyclidine and
psychostimulants are readily self-administered directly into the nucleus accumbens
and cocaine and phencyclidine are directly administered into the prefrontal cortex
of rats. Furthermore, activation of the nucleus accumbens neurons results in the
creation of a conditioned place preference (McBride, Murphy et al. 1999).
Additional drugs of abuse have been shown to involve this system of nuclei leading
to the conclusion that most drugs of abuse activate the mesolimbic dopamine
system making these featured structures the primary targets of the research done
here.
The mesolimbic dopamine system also appears to play a key role in relapse
of drug seeking, the most important area of drug addiction to study in order to
discover an effective treatment. As will be discussed in greater detail to follow,
dopaminergic activity within the mesolimbic dopamine system is involved in
reinstatement in response to a stressor (Capriles, Rodaros et al. 2003; Thiel, Wenzel
et al. 2010; Brown, Kupferschmidt et al. 2012) as well as cocaine-primed
reinstatement (McFarland and Kalivas 2001; Anderson and Pierce 2005).
Additionally, regions within this system appear to be influenced by stress as
exposure to a stressor can alter extracellular dopamine concentrations within the
NAc (Kalivas and Duffy 1995). These findings give strong support for the
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mesolimbic dopamine system being heavily involved the results of the studies
performed here. We believe activity within this system plays a key role in the
reinstatement behaviors we have seen and will be further discussed in the sections
to follow.
Self-Administration Model
Animal models are designed in order to reliably and predictably study
behaviors seen in humans. The use of animal models to study aspects of drug
addiction is possible due to the fact that the majority of drugs that have high abuse
potential in humans can be predicted with the use of such models. There are
multiple accepted models that are widely used to study the abuse-related effects of
cocaine, including conditioned place preference and intracranial self-stimulation
(Kornetsky and Esposito 1981; Hoffman 1989). In the work presented here the
intravenous rat self-administration model was used, one of the more widely used
models seen in addiction related research due to its ability to predict abuse
potential (Collins, Weeks et al. 1984).
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Figure 1. Drawing of self-administration setup for the rat. Responses on the lever
activate the programming equipment that triggers an injection into the surgically
implanted catheter in the rat.

IV Self-Administration
At first, animals and humans will both self-administer drugs for their
rewarding properties, even if not entirely dependent upon the drug. The positive or
reinforcing effects of drugs are an important part of beginning the addiction cycle. It
is partly this reinforcing property of the drug being used that causes an individual to
continue using despite negative consequences. In order to study this binge or
intoxication stage we utilize the rat self-administration paradigm. In the rat selfadministration model, a rat is implanted with an intravenous catheter and is trained
to respond, in the form of a lever press, in order to receive an infusion of drug
(cocaine). During the acquisition and maintenance phase of study the animals work
to receive an infusion of drug. The requirement to receive an infusion is controlled
by the experimenter and is most commonly set as a fixed ratio or a progressive ratio
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schedule. There are other schedules that can be used, such as a second order
schedule and a multiple schedule that use variations of the same principles
(Goldberg, Kelleher et al. 1975; Caine and Koob 1994). In the fixed ratio schedule,
as used in these studies, the number of responses required for a cocaine infusion
remains the same throughout the session, in contrast to progressive ration in which
the number of responses required for an infusion continually increases. Under fixed
ration conditions, rats quickly establish a pattern of consistent behavior over a set
duration of time and increasing the number of responses required for an infusion or
examining patterns of responding relative to conditions where the drug is not
available demonstrates that the animal is actively seeking the drug (Caine and Koob
1993). This model also uses an inactive lever to demonstrate selective behavior
towards the drug-paired lever.
Intake Conditions
As is the case in human addicts, the pattern of intake using the rat selfadministration model can vary with the history of prior drug intake (e.g. access
conditions, dosage, number of prior testing sessions). In our hands, rats are allowed
to self-administer cocaine under either limited, short-access (ShA; 2 hours/day)
conditions or extended, long-access (LgA; 6 hours/day) conditions. Rats exposed to
these different conditions exhibit characteristics unique to the level of drug intake
when examined later (Ahmed and Koob 1999; Ahmed, Walker et al. 2000). Rats
undergoing self-administration under LgA conditions show more traditional
“addicted”-like behavior. These animals show an escalation of drug intake over the
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course of the study, similar to a loss of control over the drug as one may see in a
human addict, while ShA animals demonstrate relative consistency in intake
throughout their sessions (Paterson and Markou 2003; Ferrario, Gorny et al. 2005).
Furthermore, animals with a history of LgA SA display enhanced reinstatement
when compared to ShA animals (Mantsch, Yuferov et al. 2004; Ferrario, Gorny et al.
2005). Thus the LgA model can be used to study the extreme effects of cocaine
addiction and the underlying neuroplasticity.
While long-access SA approaches can be used to model addiction in its most
extreme form, it is important to note that, as is the case in many cocaine users, selfadministration in LgA rats is both compulsive and susceptible to reinstatement.
Thus, although testing under long-access conditions is beneficial for studying
addiction-related neuroplasticity and related mechanisms, it represents and
extreme condition that may not be optimal for studying some processes that
contribute to use in many individuals who abuse and/or are addicted to cocaine.
For this reason the use of the ShA model is a better of representation of the
recreational cocaine user, which may be a better group to target for treatment.
Extinction and Reinstatement
The main focus of drug abuse research is to treat and prevent relapse of drug
seeking. Relapse of cocaine use following periods of abstinence remains the biggest
hurdle in the treatment of cocaine abuse (Gawin 1991). In order to begin to
understand the mechanisms behind relapse, we must be able to use a reliable model
and for this we use the extinction/reinstatement paradigm. To study relapse we
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must first put the animals through an extinction phase in which they are no longer
allowed access to the drug. During this phase the rats receive an inert substance,
such as saline, instead of the drug when they respond on the lever previously
associated with the drug. This eventually results in the cessation of lever pressing
behavior.
Once the animals have gone through a period of extinction and the lever
response rate has decreased to a stable, low level, they can be tested for
reinstatement. Reinstatement occurs when the lever-pressing behavior returns
following extinction, even in the absence of a cocaine reward and is meant to mimic
the chronic, relapsing characteristics of addiction. It has been well studied that
administration of an acute dose of cocaine as well as exposure to cues previously
associated with drug delivery result in reinstatement of drug seeking (Gerber and
Stretch 1975; de Wit and Stewart 1981; Slikker, Brocco et al. 1984; Meil and See
1997). Stress has also been shown to reliably produce reinstatement following
extinction and this will be discussed in more detail to follow (Erb, Shaham et al.
1996; Ahmed and Koob 1997).
It is important to note the potential use of different circuitry and mechanisms
involved in self-administration and reinstatement. Self-administration involves
presence of a reward in the form of a drug infusion. This is linked to activation of
the limbic circuitry, including the mesolimbic dopamine system (Robbins and
Everitt 1996). Reinstatement testing, however, involves the presence of drug
seeking behavior despite the absence of any reward. The circuitry involved in this
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process in response to various treatments is beginning to be mapped out and
appears to include the ventral tegmental area, dorsal prefrontal cortex, nucleus
accumbens core and ventral pallidum (McFarland and Kalivas 2001), however, the
mechanisms behind this behavior are not completely understood.
While there is no animal model that is able to perfectly mirror behavior seen
in human addicts, the rat self-administration model is a very useful and productive
tool in studying the behavior of an animal with drug exposure. The primary area for
concern when using this model is that unlike humans, the rats used in these studies
are given very little choice in their behavior as they are put in contact with the drug
on a daily basis. As mentioned before, a hallmark of addiction is the use of drug
despite negative consequences or choosing the drug over other pleasurable
behaviors. The animals in this study do not experience the same social
consequences a human would face and are therefore not choosing to use the drug
despite the consequences. Additionally, the extinction and reinstatement model
contains problems that are difficult to address. Unlike in humans, during the
extinction phase the animals used in this model have no access to the drug and are,
therefore, on forced abstinence. This obviously differs from human experiences
where the drug may always be present, but the choice is made to stop using. While
there are potential problems with this model, as in any animal model, it remains a
well-studied and accepted model that has been shown to be a valid paradigm in the
study of addiction.
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Stress and Drug Use
Multiple studies have demonstrated that individuals with anxiety or stress
related diseases, or going through stressful life events, are far more likely to relapse
back into drug use suggesting a possible connection between stress and relapse
(Kosten, Rounsaville et al. 1986; Brown, Vik et al. 1995; Shaham, Erb et al. 2000).
While this has been an extensively studied subject, the exact mechanisms behind
this link remain unknown. Extensive studies have been performed to better
understand the involvement of stress throughout all phases of addiction and drug
use.
Impact of Stress on Self-Administration
Stress is involved in every aspect of drug use and addiction. During the
acquisition phase an animal experiences the rewarding effects of the drug for the
first time and learns what is necessary to do in order to receive the drug (Goeders
and Clampitt 2002). During the acquisition phase, exposure to a stressor, such as
repeated tail pinch, electric footshock, social stress or food restriction enhances
acquisition to the drug (Piazza, Deminiere et al. 1990; Goeders and Guerin 1994).
The ability of stress to influence acquisition is dependent upon release of
corticosterone. Daily pretreatment with corticosterone results in similar increases
in drug-intake as seen following exposure to a stressor, such as electric footshock
(Mantsch, Saphier et al. 1998; Goeders 2003). Additionally, adrenalectomy prior to
acquisition prevents cocaine self-administration while not affecting the ability to
learn to press a lever for food pellets (Goeders and Guerin 1996).
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The exact mechanism through which stress and corticosterone is regulating
acquisition of cocaine seeking is not yet fully understood, but research is being done
into this area. One possible mechanism being explored involves stress-induced
activation of the dynorphin system. Dynorphin opioids are released in response to
stress and activate the -opioid receptor (Chavkin, James et al. 1982; McLaughlin,
Marton-Popovici et al. 2003; Land, Bruchas et al. 2008). Recent work has
demonstrated that activation of the -opioid receptor prior to cocaine-associated
cues can enhance the behaviors associated with the cues, suggesting that activation
of this system may enhance the learning effects of cocaine and, therefore, may be
involved in the regulation of acquisition of self-administration (Schindler, Li et al.
2010). Further work, however, needs to be done on the -opioid system as well as
other potential mechanisms in order to better understand the role of stress in the
acquisition of cocaine seeking.
During the maintenance phase of self-administration, when the animals have
learned the drug is rewarding, we can learn what effect outside influences have on
daily drug intake. It has been shown that during this period, daily exposure to
electric footshock results in the escalation of drug intake over a two-week period
(Mantsch and Katz 2007). This suggests that stress leads to increased drug intake,
which may impact plasticity in the brain as will be discussed later. This is in
agreement with studies in humans that suggest that individuals with a history of
substance abuse who are going through periods of stress or experience higher levels
of anxiety are more likely to crave drugs or alcohol (Sinha, Fuse et al. 2000; Sinha,
Fox et al. 2011).
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Impact of Stress on Reinstatement
Human studies suggest that stress is a key factor in relapse of drug seeking
(Brown, Vik et al. 1990; Sinha, Catapano et al. 1999; Sinha, Fuse et al. 2000). These
studies have shown that stressful life experiences lead to drug or alcohol use later in
life, with a greater risk for those experiencing more significant stress. The human
studies also show that exposure to stressful cues can lead to enhanced craving for
drugs the individual had previously used. While the human data suggest a link
between stress and relapse, the use of the animal model is needed in order to better
understand the mechanism. Multiple stressors have shown the ability to reinstate
drug seeking in non-humans. These stressors include electric footshock (Shaham
and Stewart 1995; Erb, Shaham et al. 1996; Ahmed and Koob 1997; Mantsch and
Goeders 1999), food deprivation (Carroll 1985) and cold swim stress (Conrad,
McCutcheon et al. 2010). The prevention of relapse remains the primary goal in this
line of research and since stress plays such a significant role in relapse,
understanding the neurobiological mechanisms underlying stress-induced
reinstatement is important in the pursuit of new therapies.
In addition to the use of physical stressors, pharmacological studies have
been performed in efforts to explore the role of stress in reinstatement.
Administration of the alpha-2 adrenoceptor antagonist yohimbine, a known
anxiogenic drug, can induce reinstatement rats (Shepard, Bossert et al. 2004).
Additionally, intercerebroventricular injections of corticotropin releasing factor
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(CRF), at doses known to initiate the stress response, result in substantial
reinstatement (Shaham, Funk et al. 1997; Erb, Petrovic et al. 2006; Mantsch, Baker
et al. 2008). Evidence also suggests that administration of CRF antagonists are
capable of blocking footshock-induced reinstatement (Erb, Shaham et al. 1998;
Shaham, Erb et al. 1998).
Both the administration of pharmacological stressors (anxiogenic drugs) as
well as exposure to physical stressors activate the hypothalamic pituitary adrenal
(HPA) axis. These data suggest that it is not the stressor itself that is influencing
reinstatement, but rather the body’s response to the stressor. It is the activation of
this system as well as the downstream effects of this activation that led us to explore
its role in stress-induced reinstatement.
Circuitry of stress-induced reinstatement
The circuitry involved in stress-induced reinstatement appears to be
somewhat distinct from that involved in cue- or cocaine-induced reinstatement. It
has been demonstrated that inactivation of either the prefrontal cortex (PFC) or the
NAc can prevent reinstatement in response to a stressor (Capriles, Rodaros et al.
2003). Separately, there appears to be involvement of the adrenergic system from
neurons in the lateral tegmental nucleus to the bed nucleus of the stria terminalis
(BNST) and central nucleus of the amygdala. It has been shown that 2adrenoceptor agonists can attenuate footshock-induced reinstatement of drug
seeking when administered systemically, implicating the norepinephrine (NE)
pathways (Shaham, Erb et al. 2000). NE projections arise from the locus coeruleus
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and the lateral tegmental nuclei, projecting to several forebrain regions and are
responsible for NE innervation of the hippocampus, frontal cortex, hypothalamus,
central nucleus of the amygdala, the septum, NAc and BNST (Moore and Bloom
1979; Foote, Bloom et al. 1983; Delfs, Zhu et al. 1998; Aston-Jones, Delfs et al. 1999).
Additionally, the locus coeruleus is activated by exposure to stressors and plays a
role in the stress response (Stanford 1995; Bremner, Krystal et al. 1996).
Initial studies have demonstrated that activation of locus coeruleus 2
adrenergic receptors does not alter footshock-induced reinstatement, but lesions
disrupting lateral tegmental NE innervation to the hypothalamus and BNST were
able to decrease such reinstatement (Shaham, Highfield et al. 2000). These data
suggest NE from the lateral tegmentum may be involved in stress-induced
reinstatement.
The BNST and central nucleus of the amygdala receive NE innervation and
are involved in the actions of CRF and the stress response (Davis, Walker et al. 1997;
Delfs, Zhu et al. 2000). Both regions also contain CRF receptors (Potter, Sutton et al.
1994). Injections of CRF antagonists into the BNST prevent footshock-induced
reinstatement, while administration of CRF itself into this region will induce
reinstatement. No effect was seen in the amygdala using either treatment (Erb and
Stewart 1999). This suggests that activation of CRF receptors in the BNST may be a
critical step in footshock-induced cocaine seeking.
The role of CRF in stress-induced cocaine seeking was demonstrated by
numerous studies (Erb, Shaham et al. 1998; Erb, Petrovic et al. 2006; Mantsch,
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Baker et al. 2008; Shalev, Erb et al. 2010; Graf, Hoks et al. 2011). The ventral
tegmental area (VTA) receives CRF projections from a number of brain regions,
including the amygdala and BNST, and has been shown to have elevated levels of
CRF following exposure to footshock (Wang, Shaham et al. 2005; Rodaros, Caruana
et al. 2007). The exact receptor type responsible for the CRF dependent effect on
stress-induced reinstatement remains controversial. Work in our lab has shown it
is mediated by activation of VTA CRF-R1, not CRF-R2 as suggested by other studies
(Wang, Shaham et al. 2005; Wang, You et al. 2007). As dopaminergic neurons from
the VTA project to the PFC and NAc, CRF activation of VTA CRF-R1 receptors may
stimulate dopamine release to the NAc and be a key mediator of stress-induced
reinstatement (McFarland, Davidge et al. 2004; Wang, Shaham et al. 2005).
Additionally, as discussed later, intracerebroventricular CRF-induced reinstatement
is augmented by high cocaine intake conditions, suggesting that this system may
undergo some level of neuroplasticity following exposure to cocaine (Mantsch,
Baker et al. 2008).
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Figure 2. Circuitry involved in reinstatement to a primer (e.g. stress, cue, drug). It is
proposed that the projection from the dorsal prefrontal cortex (dPFC) to the nucleus
accumbens core (NAc core) is the final pathway in all primed reinstatement. VTA=
ventral tegmental area, BLA= basolateral amygdala, CeA= central nucleus of the
amygdala, BNST= bed nucleus of the stria terminalis, LTN= hypothalamic lateral
tuberal nucleus. (Kalivas and McFarland 2003)
Effect of Level of Drug Intake on Stress-Induced Reinstatement
As is the case with relapse in human addicts, there is much variation in the
ability of stress to directly trigger reinstatement of cocaine seeking in rats. A
number of factors (genetics, environment, pharmacological history) likely play a
role in determining if and how stress can contribute to drug use. Several labs have
found that while there is a clear link between stress and relapse or reinstatement, it
appears that the amount of prior drug intake influences the magnitude and
likelihood of this occurring. The same stressor is capable of resulting in robust
reinstatement under certain conditions, but has little effect in others (Ahmed,
Walker et al. 2000; Mantsch, Baker et al. 2008). The level of drug intake and its
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effect on later reinstatement is one of the topics addressed in this work and may be
due to some level of drug-induced neuroplasticity, suggesting that the greater the
drug intake, the more changes that may occur in the brain.
We have demonstrated that high intake rats that have undergone exposure
to cocaine under long access (LgA; 6 hrs of cocaine exposure/day) conditions
consistently reinstate when exposed to 15 minutes of electric footshock prior to a
reinstatement session, whereas animals exposed to short access (ShA; 2 hrs of
cocaine exposure/day) conditions do not. The animals undergoing LgA exposure to
cocaine take in approximately 4X the amount of drug animals under ShA conditions
do over the course of the study (800 mg/kg vs. 200 mg/kg cocaine) (Blacktop,
Seubert et al. 2011). In addition, LgA self-administration results in a higher level of
reinstatement when pretreated with CRF and reinstates at lower doses of CRF than
do animals with ShA exposure to cocaine (Mantsch, Baker et al. 2008). This differs
from studies that do see footshock-induced reinstatement in ShA animals, but is
consistent with previous data showing a similar effect in rats exposed to footshock
following LgA or ShA heroin self-administration (Erb, Shaham et al. 1996; Ahmed,
Walker et al. 2000). These discrepancies may be explained by differences in SA and
reinstatement conditions as well as different rat strains and other altered methods
(Kupferschmidt, Brown et al. 2011) including differences in the shock intensity
(Shaham 1996) or alterations in the withdrawal or extinction phase (Shalev,
Morales et al. 2001). Surprisingly, the rats exposed to LgA SA of cocaine also
showed behavior consistent with reduced anxiety when tested in open field,
elevated plus maze and light/dark box when compared to ShA animals (Mantsch,
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Baker et al. 2008). This may be explained by a change in circuitry in these high
intake rats that leads to increased activity when confronted with stress as well as by
the evidence that addicted individuals are more likely to engage in compulsive and
high risk activities (Vanderschuren and Everitt 2004). Thus, understanding the
neurobiological mechanisms that contribute to the differences in motivation
between ShA and LgA rats may contribute to our understanding of the
neuroplasticity underlying addiction. This question is further explored in chapter 4.
While these data demonstrate the variability in the ability of stress to act as a
trigger of reinstatement, there is still a great deal to learn from the role of stress in
reinstatement under ShA conditions. In low intake rats, stress may be acting more
as a stage setter than a direct trigger of relapse. Studies using the anxiogenic drug
yohimbine shows stress in addition to a drug-associated cue resulted in far greater
reinstatement than either challenge presented alone (Feltenstein and See 2006).
The same effect was seen using acute exposure to footshock prior to a cocaineassociated cue (Buffalari and See 2009). In both of these cases stress prior to
exposure to a cue greatly elevated the level of reinstatement. This suggests that
stress may make the individual more sensitive to relapse, even under ShA
conditions.
Stress as a Stage Setter
While these data suggest a clear connection between stress and
reinstatement of drug seeking, it is not clear that stress is always a direct trigger of
relapse. Recent evidence suggests that stress may in fact act as a stage setter,
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allowing for stimuli that may not result in relapse under non stress conditions to do
so following periods of stress. It has been demonstrated that exposure to a stressor,
in the form of electric footshock or administration of an anxiogenic drug such as
yohimbine, can exacerbate cue- or context-induced reinstatement in various models
(Liu and Weiss 2002; Liu and Weiss 2003; Buffalari and See 2009). Additionally,
these effects of stress on reinstatement were seen in animals undergoing ShA SA,
suggesting it is not dependent upon excessive drug intake as seen before. The work
done here examines the ability of stress to potentiate the effect of drug-induced
reinstatement in an effort to better understand the mechanism through which stress
interacts with the relapse of drug seeking.
Monoamines and other modulators of Reinstatement
Extensive work has been done examining the circuitry involved in both the
reward circuitry as well as the circuitry involved in reinstatement. While there is
some amount of overlap between these two pathways, it is important to note that
they are distinct circuits and involve various brain regions and neurotransmitters
(Wise and Rompre 1989; McFarland and Kalivas 2001).
Dopamine
Monoamines, specifically dopamine, have been extensively studied in drug
addiction because all known drugs of abuse acutely increase dopamine levels in the
NAc, although through varying mechanisms. Because cocaine primarily acts
through blockade of dopamine transporters (Povlock and Schenk 1997), it is
important to study regions of the brain involved in the dopamine system. The
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dopaminergic cell bodies originate in the VTA and substantia nigra and project to
many brain regions known to be involved in reward and addiction, including the
PFC, NAc, hippocampus and amygdala (Hyman, Malenka et al. 2006). In particular,
it appears that activity in the VTA, dPFC, NAc and ventral pallidum are necessary for
cocaine-induced reinstatement. This is seen by administration of GABA agonists
into these regions, resulting in inactivation, that blocks cocaine-primed
reinstatement, without blocking other goal directed actions (McFarland and Kalivas
2001). It was also demonstrated that inhibition of cocaine-primed reinstatement by
GABA administration into the VTA could be reversed with dopamine directly into
the dPFC. These data in addition to data showing dopamine alone into the dPFC
results in reinstatement suggest a strong role for the dPFC in cocaine-induced
reinstatement (McFarland and Kalivas 2001). Another region, the NAc is also
heavily implicated in the reinforcing aspects of cocaine (Robbins and Everitt 1996;
Wise 2008). This makes these two regions of particular interest and the focus of the
work done here.
Studies have demonstrated that administration of dopamine or dopamine
agonists, specifically targeting the dopamine D2 receptor, directly into the NAc is
sufficient to reinstate drug seeking (Wise, Murray et al. 1990; Self, Barnhart et al.
1996; De Vries, Schoffelmeer et al. 1999; Cornish and Kalivas 2000). It has also been
demonstrated that the level to which cocaine is able to increase dopamine levels
during SA, influences the susceptibility to later reinstatement (Madayag, Kau et al.
2010). The exact mechanism behind these findings is still unclear, however. There
is debate over the role of dopamine D1 and D2 receptors as well as the brain regions
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involved. These questions are not addressed by this work, but rather are focused on
manipulations of dopamine levels and its effect on reinstatement.
Also of note to the work performed here is the ability of stress to alter
dopamine concentrations. Exposure to electric footshock has been shown to elevate
dopamine levels in the NAc (Kalivas and Duffy 1995), and that corticosterone is
necessary for this stress-induced elevation of dopamine as this effect can be blocked
by either adrenalectomy or administration of a corticosterone synthesis inhibitor
(Marinelli, Piazza et al. 1994; Rouge-Pont, Marinelli et al. 1995; Barrot, Marinelli et
al. 2000). These data suggest that any mechanism capable of altering dopamine
concentrations may play a key role in reinstatement behavior, especially as it relates
to stress.
Norepinephrine
As mentioned earlier, the noradrenergic system plays a major role in drug
use and relapse. As cocaine is a nonselective monoamine uptake inhibitor, it is
important to examine the roles of these other transmitters (Glowinski and Axelrod
1965; Iversen 1973). Evidence suggests that drugs blocking the reuptake of
norepinephrine are able to at least partially substitute for the actions of cocaine or
enhance the actions of cocaine, suggesting a rewarding property of elevated
norepinephrine (Cunningham and Callahan 1991; Baker, Riddle et al. 1993;
Spealman 1995). Norepinephrine has also been implicated in reinstatement. As
mentioned previously, administration of the 2-adrenoceptor-antagonist yohimbine
can result in reinstatement (Lee, Tiefenbacher et al. 2004; Shepard, Bossert et al.
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2004). Also, systemic administration of 2-agonists have been shown to block
footshock-induced reinstatement of cocaine seeking (Erb, Hitchcott et al. 2000).
This evidence suggests that the noradrenergic system may play a large role in drug
use and stress-induced reinstatement and is a subject that will need to be addressed
as this research continues.
Serotonin
Serotonin is synthesized in the raphe nuclei, whose projections innervate
almost all regions of the brain, and is involved in the regulation of many vital
functions of an organism (sleep, circadian rhythms, feeding, reproductive behaviors,
etc…) (Barnes and Sharp 1999). Serotonergic neurons innervate structures
involved in the actions of cocaine, such as the VTA, NAc and PFC and may play a role
in influencing the effects of the drug (Halliday and Tork 1989). It has been
demonstrated that cocaine elevates serotonin levels in the NAc through blockade of
the serotonin transporter (SERT), similar to the effect cocaine has on dopamine
(Ritz, Cone et al. 1990; Broderick, Hope et al. 2004). Elevations of serotonin have
also been shown to be rewarding as pharmacological blockade of SERT, by a drug
with no inherent rewarding properties, caused conditioned place preference in mice
(Filip, Frankowska et al. 2005).
Substantial work has been done in order to better understand which of the
many serotonin receptor subtypes are involved in cocaine use. Pharmacological
blockade of 5-HT2A receptors and activation of 5-HT2C receptors block the locomotor
effects of cocaine, while activation of 5-HT2A and blockade of 5-HT2C enhance it
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(McCreary and Cunningham 1999; Fletcher, Grottick et al. 2002; Filip, Bubar et al.
2004). Additionally, 5-HT2A antagonists have no effect on cocaine selfadministration (Fletcher, Grottick et al. 2002), while 5-HT2C antagonists increase
and 5-HT2C agonists decrease cocaine self-administration (Fletcher, Grottick et al.
2002; Fletcher, Chintoh et al. 2004). Finally, blockade of the 5-HT2A receptor or
stimulation of the 5-HT2C attenuates cocaine and cue-induced reinstatement
(Grottick, Corrigall et al. 2001; Fletcher, Grottick et al. 2002; Neisewander and
Acosta 2007).
These data suggest a clear role of the serotonergic system in the
reinstatement of cocaine-seeking behavior. While this system is not as well
understood as others, such as the dopamine system, it still may play a key role in the
reinstatement process and while not addressed in the work done here, may be
important to examine in the future.
Kappa Opioid System
Another system involved in the stress response and reinstatement is the
kappa opioid system. Stress, and activation of the HPA axis, results in activation of
the endogenous  opioid system (Przewlocki, Lason et al. 1987; Watanabe, Weiland
et al. 1995). Increased activity of the  opioid system has been demonstrated be a
key mediator the ability of stress to alter the reinforcing properties of cocaine
(McLaughlin, Marton-Popovici et al. 2003). Studies have shown that pretreatment
with a kappa receptor antagonist prevents reinstatement of drug seeking following
exposure to footshock or forced swim stress (Beardsley, Howard et al. 2005; Carey,
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Borozny et al. 2007). Additionally, in a series of mouse studies, it has been shown
that reinstatement of cocaine seeking following exposure to stress, but not a cocaine
primer, is dependent upon kappa opioid receptor activation. Exposure to footshock
or forced swim, as well as administration of a kappa agonist resulted in
reinstatement under the mouse conditioned place preference model. This effect
was completely blocked when done in the presence of a kappa antagonist or when
performed in mice lacking kappa opioid receptors or the endogenous opioid,
dynorphin (Redila and Chavkin 2008). This suggests that dynorphin and kappa
receptor activation may play a role in stress-induced reinstatement.
Furthermore, there may be a connection between the kappa opioid system
and CRF. Studies have shown that CRF and dynorphin are expressed in the same
brain regions (Roth, Weber et al. 1983) and CRF can induce dynorphin release
(Sirinathsinghji, Nikolarakis et al. 1989). Considering the significant role of CRF in
stress-induced reinstatement, as discussed earlier, this connection may be an
important aspect in this form of reinstatement and may need further examination in
the future.
Stress Response and Homeostasis
The activation of the hypothalamic pituitary adrenal (HPA) axis is vital for an
organism to be able to adapt and survive in the presence of real or perceived stress.
Corticosteroid release exerts its adaptive and life-saving effects by mobilizing
substrates needed for energy and shutting down systems involved in maintaining
the immune system and inflammatory response. This prevents these responses
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from being overactive and causing harm to the organism(Sapolsky, Romero et al.
2000). This may play a key role in addiction as well. As an individual consumes a
drug, the body may need to adjust in order to account for the presence of the drug,
resulting in a potential dysregulation of the HPA axis.
Exposure to a stressor, or any deviation from homeostasis past a certain
point results in the activation of the HOA axis. This involves release of corticotropin
releasing factor (CRF) from the parvocellular neurons in the paraventricular nucleus
(PVN) of the hypothalamus (Figure 3). CRF release triggers activation of the HPA
axis and results in a glucocorticoid response, which allows corticosteroids to reach
every organ of the body and leads to a number of behavioral adaptations aimed at
returning the organism to homeostasis (McEwen 1998; de Kloet, Joels et al. 2005).
The release of glucocorticoids, including corticosterone in the case of rodents or
cortisol in humans, allows for the organism to mount a response to the challenge
presented, making this an important system in survival (McEwen and Stellar 1993).
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Figure 3. Schematic of the HPA axis. (Adapted from UCLA Center for Neurovisceral
Sciences and Women’s Health)

The release of corticosteroids from the adrenal gland is regulated by
adrenocorticotropic hormone (ACTH) that originates from the anterior pituitary
gland (Swanson, Sawchenko et al. 1987). The nature of the stress encountered has a
major impact on the release of ACTH and processing of the stressor occurs in limbic
structures such as the amygdala, hippocampus and frontal cortex, which modulate
the PVN and surrounding areas (Herman, Cullinan et al. 2002). This pool of ACTH is
then tightly regulated by CRF that originates from the hypothalamus. In addition,
the corticosterone that is released from the adrenal gland exerts negative feedback
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on the release of both ACTH and CRF at the pituitary and the PVN. Acutely,
glucocorticoids inhibit the release of CRF relatively quickly, while chronically they
downregulate expression of CRF expression in the PVN (Keller-Wood and Dallman
1984). All of these features allow for a well-balanced and tightly regulated stress
response. This allows the organism to react differently to a wide variety of stressors
(physical, psychological, real or imagined) in a different manner and return to
homeostasis in a timely manner. In the studies presented here, we explored the role
of these stress-related hormones in the mechanism involved in stress-induced
reinstatement.
Corticosteroid Receptors
The mechanism involved in the response to corticosteroid release involves
both rapid and slow responses. The system involved in the slow, genomic response
typically consists of two different, but related receptors, the mineralocorticoid
receptor (MR) and the glucocorticoid receptor (GR). Both receptors bind to the
same hormone, cortisol in humans and corticosterone in the rat, but MR has a
tenfold higher affinity (Reul and de Kloet 1985). MR affinity is much higher than
that of GR, allowing it to remain activated at most times, even in between bursts of
hormone secretion. GR, however, has a lower affinity for the hormone and appears
to be primarily activated during times of stress and circadian rhythm induced
elevations of corticosteroid concentrations (Kitchener, Di Blasi et al. 2004). This
means stress-induced increases in glucocorticoid levels appear to have a greater
impact on GR, making it the receptor of focus here.
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GR are distributed throughout the brain in both neurons and glial cells. GR density
is at its highest in the PVN and structures of the limbic system, making it readily
accessible to the actions of the HPA axis (Miklos and Kovacs 2002; Herman,
Figueiredo et al. 2003). Expression is also relatively high in areas such as the
striatum (NAc) and BNST (Morimoto, Morita et al. 1996). The limbic structures also
express a significant amount of MR and there are a number of regions, especially the
hippocampus, that have a large amount of co-expression of MR and GR, which can be
seen across many species (Patel, Lopez et al. 2000).
Upon interaction with corticosteroids, MR and GR are capable of forming
heterodimers, homodimers and monomers, which allows the receptors to respond
to a large variation in corticosteroid concentration (Trapp, Rupprecht et al. 1994).
These activated corticosteroid receptors have the ability to regulate gene
transcription and are capable of regulating the expression of a large number of
genes, up to 100 in the hippocampus alone, with many being responsive to
activation of either receptor (Datson, van der Perk et al. 2001). This is done when
the activated receptors translocate into the nucleus of the cell and bind to DNA or
interfere with the activity of various transcription factors (Deroche-Gamonet,
Sillaber et al. 2003). Activation of these receptors and the subsequent regulation of
gene transcription and translation is part of a system involved in managing many
molecular and cellular changes that may play a role in a wide variety of behaviors,
such as memory formation and motivated behaviors.
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Nongenomic Mechanisms
Since activation of GR requires translocation to the nucleus and regulation of
gene transcription, the process can take over an hour to develop and the effects can
last days (Joels and Baram 2009). Corticosterone increases in the brain are also not
immediate and when considered along with the time necessary for gene
transcription and translation, GR-dependent genomic mechanisms may play little
role in acute behavioral responses. This suggests the possibility of a stage setting
effect for glucocorticoids opposed to a direct triggering mechanism. In addition,
there is growing evidence of rapid glucocorticoid actions through nongenomic
mechanisms, with actions occurring with seconds or minutes (Tasker, Di et al. 2006;
Haller, Mikics et al. 2008). These effects include rapid increases in locomotor
activity dependent upon nitric oxide release (Sandi, Venero et al. 1996) and
suppression of male reproductive behavior through regulation glucocorticoid
receptor activity (Rose, Moore et al. 1993; Rose and Moore 2002). Additionally,
acute elevations in glucocorticoid levels can have advantageous effects on memory
formation (Roozendaal 2003), while long term elevations can be harmful (de
Quervain, Roozendaal et al. 1998).
In addition to the rapid inhibition of the HPA axis as mentioned earlier,
glucocorticoids also appear to exert rapid effects through membrane-associated
receptors distinct from the traditional mechanism of action (for review see, (Tasker,
Di et al. 2006). The identity of these receptors is not yet fully understood, but it
appears that glucocorticoids may be functioning through G protein-coupled
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receptors (Orchinik, Murray et al. 1991). The behavioral effects seen in the data
presented below occur relatively soon after glucocorticoid elevation suggesting a
non-GR mediated mechanism. It is our goal to provide a potential mechanism
through which these rapid effects are occurring in our model.
Glucocorticoid Hormones and Cocaine Abuse
Substantial research has been done examining a connection between
glucocorticoid hormones and the vulnerability of an individual to cocaine addiction
(Goeders 2002). Stress-induced activation of the HPA axis and the subsequent
release of glucocorticoids result in actions throughout the brain, including neurons
containing dopamine (Piazza and Le Moal 1996). Glucocorticoids play a key role in
the acquisition, maintenance and reinstatement of cocaine self-administration,
suggesting they are very important in all aspects of cocaine abuse (Goeders and
Guerin 1996; Deroche, Marinelli et al. 1997; Mantsch and Goeders 1999). In
addition, it has been demonstrated that giving rats repeated injections of
corticosterone will allow them to acquire and self-administer cocaine at lower doses
than animals not receiving corticosterone. Additionally, adrenalectomized rats selfadminister cocaine at a lower rate when compared to animals with a functioning
adrenal response (Piazza, Rouge-Pont et al. 1996; Mantsch, Saphier et al. 1998). In
attempt to understand the mechanism behind this interaction, it has been
hypothesized that the glucocorticoid response that occurs following drug exposure
contributes to the neuroplasticity seen in rats with a history of drug intake (Kreek
and Koob 1998).
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Drug Induced Plasticity
Evidence suggests LgA exposure to cocaine results in some level of
neuroplasticity not seen in ShA rats. There appears that cocaine SA produces intake
dependent, long-term neuroadaptations that lead to an increased sensitivity to
stress-induced reinstatement (Mantsch, Baker et al. 2008). It has been suggested
that drug-induced alterations in the stress response may be responsible for the
neuroplasticity seen in LgA animals (Kreek and Koob 1998; Koob and Kreek 2007).
Like stressors, cocaine, whether administered non-contingently or selfadministered, activates the HPA axis resulting in elevated plasma corticosterone
levels. ShA and LgA conditions result in the same peak corticosterone level, but rats
undergoing LgA drug intake show a sustained elevation of corticosterone for a
significantly longer period of time over a 24-hour span (Mantsch, Baker et al. 2008).
This sustained elevation and increase in overall corticosterone levels may create an
environment that promotes addiction-related plasticity.
Interestingly, when this alteration in elevated glucocorticoids is prevented
through adrenalectomy, the differences in behavior seen between ShA and LgA
cocaine exposure is diminished. Rats adrenalectomized prior to LgA cocaine SA do
not show reinstatement following exposure to footshock or i.c.v. administration of
CRF (Graf, Hoks et al. 2011). In fact, animals without the glucocorticoid response
behave similarly to ShA animals. This effect of adrenalectomy on later footshockinduced reinstatement was only seen when the surgery was performed prior to the
beginning of the SA phase. When performed following SA, but prior to
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reinstatement testing, the rats behaved responded to footshock similarly to intact
animals. The reinstatement of cocaine-seeking behavior despite the lack of an active
corticosterone response to stress is consistent with previous reports using both
cocaine and heroin (Shaham, Funk et al. 1997; Erb, Shaham et al. 1998). This
suggests that stress-induced relapse does not require acute stress-induced increases
in corticosterone levels. It is important to note that while elevations in
corticosterone are not necessary for reinstatement under these conditions, it is
necessary in order to create the stage setting effect as will be seen in chapter 1. This
further demonstrates the difference between stress acting as a stage setter or
functioning as a trigger or mechanism responsible for neuroplasticity. The data also
suggest that adrenal responses during the SA phase are necessary for the induction
of plasticity that is seen under LgA conditions that contributes to later relapse.
Failure to have normal cocaine-induced adrenal responses results in the lack of later
footshock induced reinstatement normally seen in intact LgA animals. We
hypothesize that this plasticity is a result of a chronic cocaine SA-induced elevation
of glucocorticoid levels. This, however, requires more examination to fully
understand the mechanism behind the adrenal response and its effect on
neuroplasticity.
GR Involvement in Reinstatement
Multiple studies have shown a significant role of GR in cocaine selfadministration and reinstatement. A mouse model in which GR has been knocked
out specifically in the CNS demonstrates a severely blunted motivation to self-
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administer cocaine as evidenced by a downward shift in a cocaine dose response
curve (Deroche-Gamonet, Sillaber et al. 2003). These data may need additional
analysis as the mice lacked GR throughout development and may have additional
behavioral deficits.
Experiments using the GR competitive antagonist, mifepristone (or RU38486), were also done to analyze the effect of GR in a progressive ratio model. In
this model, the number of responses needed to receive one infusion of cocaine
continually increases throughout the session and the amount of work they are
willing to exert to receive an infusion, or “breaking point”, is recorded. It was found
that acute mifepristone dose-dependently lowered the “breaking point” in rats with
the highest motivation to self-administer (Deroche-Gamonet, Sillaber et al. 2003).
This, together with data demonstrating a similar result in animals with decreased
endogenous glucocorticoid levels, suggest that glucocorticoid activation of GR can
increase the rewarding properties of cocaine (Deroche, Marinelli et al. 1997).
Examination of these studies suggests a role for GR throughout addiction and
reinstatement and altered gene regulation may have an impact on drug seeking. It is
again worth noting that these studies involved chronic blockade of GR, creating a
similar problem as seen in the GR knockout model. There is no current evidence for
the ability of acute GR blockade to interfere with acute stress-, cocaine-, or cueinduced reinstatement. It appears as though such an effect would be unlikely
considering the time course necessary for HPA activity and a genomic response to
GR activation as it relates to behavior.
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Non-GR Mechanisms
While many glucocorticoid interactions with GR demonstrate a slow,
genomic mechanism, there are rapid, nongenomic, and in some cases GRindependent effects known to occur (Makara and Haller 2001). One of the first
studies giving strong evidence for a nongenomic action of glucocorticoids used
electrophysiological recordings of the PVN. In this study it was shown that
glucocorticoids were able to very quickly inhibit glutamate release onto
parvocellular neurons (Keller-Wood and Dallman 1984; Di, Malcher-Lopes et al.
2003). These effects occur in a time course suggesting that they are not associated
with gene transcription, but the exact mechanisms are not yet fully understood.
Potential nongenomic pathways include activation of the nitric oxide system, the
release of endocannabinoids, and other non-traditional receptors. The work
presented here aims to examine a potential GR-independent mechanism involved in
modulating cocaine use.
One non-genomic mechanism of glucocorticoid action involves the
endocannabinoid system. Endocannabinoids are retrograde messengers that are
capable of modulating many behaviors(Wilson and Nicoll 2002). There are
currently two identified cannabinoid receptors, CB1 and CB2, with CB1 being
expressed throughout the central nervous system and CB2 primarily expressed in
the periphery. When endocannabinoids are released from a postsynaptic cell
following depolarization, the presynaptic CB1 receptors are activated. This results
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in the inhibition of neurotransmitter release, both excitatory and inhibitory
(Maldonado, Valverde et al. 2006). Additionally, these receptors are abundantly
expressed throughout the mesolimbic dopamine system, including the NAc and VTA,
where they can influence glutamatergic and GABAergic signaling (Robbe, Kopf et al.
2002; Melis, Pistis et al. 2004).
These data suggest that the endocannabinoid system may play a key role in
reward circuitry and addiction through regulation of neurotransmitter release.
Interestingly, this system also appears to be heavily influenced by stress and
glucocorticoids. Activation of glucocorticoid receptors, through a G proteinsignaling cascade, has been shown to induce the synthesis of endocannabinoids,
leading to presynaptic activation of the CB1 receptor (Di, Malcher-Lopes et al. 2003).
This rapid, stress-induced activation of the endocannabinoid system and the effects
it has on reward circuitry may represent a potential mechanism behind stressinduced relapse, including some of the effects seen in the work presented here. This
idea, however, is still poorly understood and requires further research by our lab
and others before more definitive conclusions can be made.
Glucocorticoids and Dopamine
Previous work suggests that glucocorticoids may directly regulate dopamine
levels by either pre- or post-synaptic mechanisms. A large population of dopamine
neurons in the VTA also express corticosteroid receptors (Harfstrand, Fuxe et al.
1986). GR is expressed on most cell types throughout the reward circuitry,
including the NAc and PFC (Barik, Parnaudeau et al. 2010). Glucocorticoids also
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appear to play a role in dopamine-mediated behaviors as evidenced by a series of
behavioral studies in adrenalectomized animals (Marinelli, Piazza et al. 1994).
These dopamine-mediated behaviors have also shown to increase during periods of
elevated corticosterone and coincide with elevations in extracellular levels of
dopamine in the NAc (Piazza, Rouge-Pont et al. 1996). These studies suggest that
glucocorticoids modulate NAc dopamine concentrations and may explain human
findings showing glucocorticoid-induced psychosis (Hall, Popkin et al. 1979; Ling,
Perry et al. 1981). The exact mechanism responsible for the impact of
glucocorticoids on dopamine transmission is currently unknown and the work
presented here may give a possible explanation.
Organic Cation Transporter 3
One potential mechanism by which glucocorticoids may alter dopamine
clearance, and therefore influence behavior, is through inhibition of OCT3-mediated
dopamine clearance. Organic cation transporter3 (OCT3) is a high capacity
transporter involved in the bidirectional transport of dopamine and other
monoamines including norepinephrine, epinephrine, histamine and serotonin
(Grundemann, Schechinger et al. 1998; Grundemann, Liebich et al. 1999). OCT3 is
expressed throughout the body, including the brain, and is highly sensitive to
inhibition by glucocorticoids, such as corticosterone, making it an interesting
mechanism of monoamine clearance to study (Simmonds and Gillis 1968;
Grundemann, Koster et al. 1998; Gasser, Orchinik et al. 2009).
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OCT3 is part of a group of transporters responsible for uptake2 activity.
Uptake2 is a higher capacity, but lower affinity transport system when compared to
uptake 1 transport, which is comprised of the specific transporters for
norepinephrine (NET), dopamine (DAT) and serotonin (SERT) (Simmonds and Gillis
1968; Iversen and Salt 1970). For example, rat DAT binding affinity (Km) for
dopamine is in the range of 800 nM (Giros, el Mestikawy et al. 1991; Kilty, Lorang et
al. 1991), compared to OCT3 affinity for dopamine at ~1000 M (Duan and Wang
2010). This significant difference in substrate affinity assures that OCT3 will act as a
backup clearance mechanism, acting as a sink for monoamine spillover.
The significance of uptake2-mediated clearance can be seen in studies in
which these transporters are inhibited by bath application of corticosteroids in
cardiac and smooth muscle tissue. In these studies corticosteroids acutely enhance
the contractile effects of bath applied epinephrine, norepinephrine, serotonin or
histamine (Kalsner 1975; Purdy, Weber et al. 1982; Purdy and Weber 1983;
Horvath, Sutto et al. 2003). These data suggest that inhibition of uptake2, during
periods where primary transporters are saturated, can result in a significant
alteration in activity. Uptake2 is also unique in comparison to uptake 1 in that its
activity is acutely inhibited by the stress hormone corticosterone, as well as other
steroids (Simmonds and Gillis 1968; Iversen and Salt 1970; Grundemann,
Schechinger et al. 1998). Uptake2 can also be potently inhibited by
normetanephrine. Normetanephrine is the O-methylated metabolite of
norepinephrine and it has been found that its most prominent role is to inhibit the
actions of uptake2 (Goldstein, Eisenhofer et al. 2003; Rahman, Ring et al. 2008).
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Furthermore, recent studies have indicated the presence of uptake2 transporters in
the brain, making this mechanism of great interest to our research regarding the
role of stress and its ability to regulate dopamine concentrations (Engel, Zhou et al.
2004; Amphoux, Vialou et al. 2006; Gasser, Lowry et al. 2006; Gasser, Orchinik et al.
2009).
Uptake2-mediated transport is thought to involve a number of transporters
in addition to OCT3. These include OCT1, OCT2 as well as the plasma membrane
monoamine transporter (PMAT), which are expressed throughout the body,
including the brain (Grundemann, Schechinger et al. 1998; Engel, Zhou et al. 2004;
Gasser, Orchinik et al. 2009). The OCTs are part of the solute carrier 22 family and
transport small, hydrophilic organic cations through a sodium-independent
mechanism (Koepsell, Schmitt et al. 2003; Koepsell and Endou 2004). The OCTs
share similar amino acid sequences as well as structures, including 12transmembrane domains (Koepsell, Schmitt et al. 2003; Wright and Dantzler 2004).
All of the OCTs are about 555 amino acids in length and are located in the plasma
membrane (Schomig, Lazar et al. 2006). Additionally, all substrates for the OCTs
must have a single positive charge and transport is not dependent upon a Na+ and
Cl- gradient (Schomig, Lazar et al. 2006). In humans, OCT1 and OCT2 are mainly
found in the liver and kidney where they are involved in the process of organic
cation elimination (Simmonds and Gillis 1968), whereas OCT3 is found in the liver,
heart, placenta, skeletal muscle, kidney and brain (Gorboulev, Ulzheimer et al. 1997;
Zhang, Dresser et al. 1997; Grundemann, Schechinger et al. 1998). The membrane
transporter PMAT is most abundantly expressed in the brain in humans, but can
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also be found in the liver, kidney and heart (Engel, Zhou et al. 2004). While not
genetically related to the OCTs, PMAT shares many functional similarities and hence
they are grouped together in uptake2 activity.
Corticosterone-induced inhibition of uptake2 activity varies among the
multiple transporters. The half-maximal inhibitory concentration (IC50) values for
corticosterone are ~150 M (rat OCT1), ~4 M (rat OCT2), ~0.04 M (rat OCT3)
and ~450 M (PMAT) (Wu, Kekuda et al. 1998; Engel and Wang 2005; Schomig,
Lazar et al. 2006). As OCT3 has the greatest sensitivity to inhibition by
corticosterone, it may play the most important role in uptake2 mediated
monoamine transport, especially during periods of stress. This also suggests that
PMAT may not be inhibited by physiologically relevant levels of corticosterone and
will, therefore, not be affected by stress-induced fluctuations (Engel and Wang
2005).
Additionally, all the transporters are capable of transporting norepinephrine,
epinephrine, serotonin, dopamine, histamine and the neurotoxin 1-methyl-4phenylpyridium (MPP+) with varying efficiency and can also be inhibited by the
compound decynium-22, while being unaffected by the GR antagonist RU38486
(Grundemann, Schechinger et al. 1998; Grundemann, Liebich et al. 1999; HayerZillgen, Bruss et al. 2002; Horvath, Sutto et al. 2003; Engel, Zhou et al. 2004). In
particular, PMAT has a higher affinity for serotonin and dopamine than
norepinephrine and epinephrine (Engel, Zhou et al. 2004), in comparison to OCT3,
which shows an opposite pattern of affinity (Grundemann, Schechinger et al. 1998).
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OCT3 does, however, transport dopamine with greater affinity than either OCT1 or
OCT2. As compared to transport of MPP+, OCT1 has a relative transport efficiency
for dopamine of ~20%, and OCT2 <5%, whereas OCT3 has a relative transport
efficiency of dopamine of ~30% that of MPP+ (Schomig, Lazar et al. 2006). It has
also been shown that OCT3 is relatively insensitive to cocaine, as seen by an
inhibition constant (Ki) above the millimolar range, whereas OCT1 and OCT2 can be
inhibited by cocaine with the Ki ranging from 13.3 M (OCT1) to 23.8 M (OCT2)
(Amphoux, Vialou et al. 2006). Based on these data we have chosen OCT3 as the
transporter most likely to be involved in a mechanism for stress-induced elevations
of dopamine and has, therefore, been the focus of this research. It is the most
sensitive to elevations in corticosterone that may result from exposure to stress,
especially when compared to PMAT, is located throughout the brain including the
NAc and PFC and has a greater affinity for dopamine than the other members of the
OCT family making it a good candidate for further examination.
All of the transporters involved in uptake2 activity are expressed in the
rodent and human brain, although at varying levels (Engel, Zhou et al. 2004;
Amphoux, Vialou et al. 2006; Gasser, Lowry et al. 2006; Gasser, Orchinik et al. 2009).
However, OCT3 appears to be the most abundant of the transporters expressed in
the brain, making it the primary transporter of interest for the work done here
(Vialou, Balasse et al. 2008; Gasser, Orchinik et al. 2009). Recent work suggests that
within the brain, inhibition of uptake2 activity significantly alters extracellular
monoamine levels. Decynium-22 induced inhibition of uptake2 has been shown to
decrease the rate of serotonin clearance within the mouse hippocampus, which

49
could result in elevated serotonin levels (Baganz, Horton et al. 2008). In addition,
treatment of rats with normetanephrine, the potent inhibitor of uptake2,
potentiates the elevation in extracellular norepinephrine caused by treatment with
the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine (Rahman, Ring
et al. 2008). Finally, knockout mice lacking the expression of OCT3, showed
elevated levels of extracellular dopamine in the striatum (Cui, Aras et al. 2009). The
results of these studies demonstrate the importance of uptake2 activity in
regulating the level of extracellular monoamines. Any disruption in OCT3 function
has a significant impact on monoamine clearance and can result in elevated levels of
monoamines, especially when OCT3 is inhibited in the presence of an uptake1
blocker or saturation. This could have numerous impacts on multiple types of
behavior.
As discussed earlier, reinstatement of drug seeking involves the elevation of
dopamine in the NAc as well as the PFC, both areas in which OCT3 is expressed
(Wise, Murray et al. 1990; Self, Barnhart et al. 1996; De Vries, Schoffelmeer et al.
2002). Additionally, OCT3 functions as a dopamine transporter and its actions are
inhibited by corticosterone (Iversen and Salt 1970; Grundemann, Schechinger et al.
1998). Therefore, we propose that stress-induced elevations of corticosterone will
result in the blockade of OCT3-mediated dopamine clearance, resulting in increased
dopamine concentrations in the presence of other triggers (Figure 4). This suggests
stress is acting as a stage setter, making the system more susceptible to elevations in
dopamine, and allowing triggers that may not be able to cause reinstatement under
non-stress conditions to do so in periods of stress. Furthermore, intake dependent
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changes in OCT3 expression following LgA exposure to cocaine may be involved in
determining susceptibility to reinstatement seen in animals with different histories
of cocaine intake.

Basal

Stress

Figure 4. Model of OCT3-mediated regulation of monoamine clearance. Under basal
conditions, OCT3 limits the spread of released monoamines. During stress,
inhibition of OCT3-mediated monoamine clearance by corticosterone, in
combination with increased local monoaminergic neuronal activity, leads to
increases in local concentrations of monoamines. Red= Dopamine, Blue= Dopamine
transporter, Green= OCT3
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In the following studies we will demonstrate:
Chapter 1
-Stress potentiates cocaine-induced reinstatement through a GR-independent
mechanism
Chapter 2
-The NAc and PFC are key structures involved in stress-induced potentiation of
cocaine-induced reinstatement
-Corticosterone potentiates cocaine-induced elevations in extracellular dopamine in
the NAc
Chapter 3
-OCT3 is expressed in proximity to TH-containing cells in the NAc
-Inhibition of OCT3 with normetanephrine potentiates cocaine-induced
reinstatement
Chapter 4
-Chronic elevations in corticosterone and excessive cocaine intake result in
neuroplasticity that alters later relapse potentially through a decrease in OCT3
expression
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We hypothesize that stress acts to set the stage for subsequent reinstatement
through corticosterone-induced inhibition of OCT3, making the individual
vulnerable to elevations in dopamine levels capable of causing reinstatement.
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Chapter II. EFFECT OF GLUCOCORTICOIDS ON COCAINE-INDUCED
REINSTATEMENT OF COCAINE SEEKING

Introduction
It has long been known that stress plays an important role in relapse of drug
use in individuals recovering from drug addiction; however, the exact mechanism is
still not fully understood. Early theories suggested a stress-coping model in which
addictive substances are used in order to reduce the negative affect found during
periods of stress (Shiffman 1982). Recent evidence suggests that in some cases, the
role of stress may be far more complex than simply being a direct trigger for
continued drug use (Sinha 2001). Studies have shown that reinstatement in
response to physical stressors, such as electric footshock (EFS), can be context
dependent such that they will not cause reinstatement when administered in a
setting not connected with previous drug intake (Shaham, Erb et al. 2000), while
others have shown stress affects reinstatement of different drugs of abuse in
different ways (Sinha 2001).
The complexity of stress’ role in reinstatement is demonstrated by our
inability to observe reliable reinstatement with EFS in rats with a history of ShA
cocaine self-administration in the absence of additional cues or cocaine at the time
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of reinstatement testing (Mantsch, Baker et al. 2008). This effect has also been
shown by others as well and suggests that stress may be acting as a stage setter,
allowing for the potentiation of other reinstatement triggers, such as cues
(Feltenstein and See 2006; Buffalari and See 2009). This stimulus, that would not
cause reinstatement under stress-free conditions, may be able to result in the
reinstatement of drug use if the exposure occurs during periods of stress. Gaining a
better understanding of this relationship may allow us to gain further insight into
the mechanisms through which stress can lead to further drug use.
The mechanisms behind the actions of stress in reinstatement of cocaineseeking behavior are still relatively unknown despite a large amount of research
focused on this area. Several studies have demonstrated that electric footshock is
capable of causing reinstatement in animals with a history of excessive (LgA)
cocaine use (Erb, Shaham et al. 1996; Ahmed and Koob 1997; Mantsch and Goeders
1999). Other stressors, such as food deprivation and the induction of a stressed-like
state with administration of CRF can also result in reinstatement behavior (Shaham,
Funk et al. 1997; Shalev, Highfield et al. 2000; Mantsch, Baker et al. 2008). This
reinstatement behavior, however, appears to be influenced by the activity of
glucocorticoids, especially corticosterone.
Interestingly, these elevations in glucocorticoid activity appear to play a
different role at the time of reinstatement testing than during earlier phases of the
addiction process. Blockade of acute increases in corticosterone in LgA animals by
adrenalectomy after LgA SA, but prior to extinction and reinstatement showed no
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effect on footshock-induced reinstatement (Graf, Hoks et al. 2011). Blocking the
synthesis of corticosterone with metyrapone showed similar results. Under these
conditions, footshock-induced reinstatement of heroin seeking was not affected
(Shaham, Funk et al. 1997). While these data suggest that glucocorticoids are not
directly involved in mediating reinstatement at the time of testing, their exact role
has not been fully examined. It has been demonstrated that corticosterone is
necessary in order for SA to occur as adrenalectomy prevents cocaine SA, and this
effect can be reversed with corticosterone replacement (Deroche, Marinelli et al.
1997). We predict that stress, and elevations in glucocorticoid levels, has a potential
stage setting effect in which they make the individual more susceptible to
reinstatement from another trigger.
In order to better understand this point, substantial research has been done
examining the actions of glucocorticoids on behavior through activation of the
glucocorticoid receptor (GR). Through this pathway, glucocorticoids are able to
alter neuronal activity through changes in gene expression, a process that does not
occur on a rapid time scale. More recent research, however, has focused on the
acute effects of glucocorticoids acting through rapid, non GR-mediated mechanisms,
including the modulation of glutamate and GABA release as well activation of the
mineralocorticoid receptor (Di, Maxson et al. 2009; Pasricha, Joels et al. 2011). This
is of particular importance in order to better understand the ability of stress to
influence behavior on a rapid time scale, before alterations in gene translation could
alter behaviors such as reinstatement.
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In the experiments performed here we examined the ability of acute stress to
alter cocaine-induced reinstatement. We examined if the effects of acute stress on
reinstatement are dependent upon elevations of glucocorticoid and if an increase in
GR activation is required. The results of these experiments suggest a role for a
corticosterone-dependent mechanism that potentiates cocaine-induced
reinstatement independent of GR activation. These findings may aid in gaining a
better understanding of the acute effects of stress on behaviors such as
reinstatement.
Materials and Methods
Animals. Male Sprague-Dawley rats (Harlan Laboratories, Inc., St Louis, MO),
weighing 275-325 g, were housed individually in a temperature- and humiditycontrolled, AAALAC-accredited vivarium under a 12h/12h reversed light- dark cycle
(lights off at 0700 h) with ad libitum access to food and water. Procedures were
carried out in accordance with the NIH Guide for the Care and Use of Laboratory
Animals.
Jugular catheterization. Rats received indwelling jugular catheters under
ketamine/xylazine (100 mg/kg; 2 mg/kg, ip) anesthesia as previously described
(Mantsch, Baker et al. 2008; Graf, Hoks et al. 2011). Briefly, a silicon-tubing catheter
(Silastic, Dow Corning Co., Midland, MI; 0.64 mm i.d.; 1.19 mm o.d.) was inserted
into the right posterior facial vein and down into the jugular vein, terminating at the
right atrium. The catheter was then continued subcutaneously to the animal’s back
where it exited posterior to the scapula via a back mounted cannula. Lines from the
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cannula were connected to syringe pumps (Razel, Stamford, CT) via fluid swivels
(Instech Lab. Inc., Plymouth Meeting, PA) suspended above the chambers.
Swivel/leash assemblies were balanced to permit unrestrained movement.
Cocaine self-administration, extinction and reinstatement. Self-administration
was conducted using computer- interfaced operant conditioning chambers
contained in sound-attenuating cubicles (Med Associates, St. Albans, VT). Following
recovery from surgery, rats were trained to self-administer cocaine (0.5 mg/kg/200
μl, iv) by pressing a lever under a fixed ratio one schedule during daily 2-h sessions.
Cocaine infusions were accompanied by illumination of a light followed by a 25-s
time out period during which the light was extinguished but the lever remained
extended. Responding on a second, inactive lever was also recorded. Once stable
responding was observed ( <10% variation in daily responding over 3 consecutive
sessions) rats underwent an additional 14 days of daily self-administration prior to
a period of extinction training consisting of daily sessions during which the cocaine
solution was replaced with saline. Once extinction criterion was met ( 10 active
responses/session across 3 sessions), each rat was tested for reinstatement.
Reinstatement sessions were identical to extinction except that they were preceded
by the delivery of an experimental treatment (e.g. footshock, corticosterone, or
vehicle) and then the administration of a low dose of cocaine (2.5 mg/kg; i.p.) (or
saline). Reinstatement was defined as an increase in responding on the lever
previously reinforced by cocaine compared to the preceding extinction session.
Inactive lever pressing was recorded during reinstatement but is not reported due
to a lack of significant effects.
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Experiment 1. Effects of stress on cocaine-seeking following administration of
low-dose cocaine. Here we examined the influence of stress on the reinstatement
to a subthreshold dose of cocaine that does not otherwise result in reinstatement.
After extinction training, rats (n =7) were placed into self-administration chambers
for 15 min, during which they received either no shocks (CTRL) or a series of
intermittent uncontrollable electric footshocks (EFS: 0.5 mA, 0.5 s duration, mean
intershock interval = 40 s (range 10-70 s)) through the grid floor. Response levers
were retracted during this period. Immediately after EFS, rats received an injection
of cocaine (2.5 mg/kg, i.p.), at a dose that does not reinstate when given alone, or
saline, and were tested for reinstatement. All rats were tested four times in a
counterbalanced sequence, such that each rat received each of the following
treatments: EFS + saline; EFS + cocaine; CTRL + saline; CTRL + cocaine. Between
consecutive reinstatement tests, rats underwent additional extinction sessions until
they again met extinction criterion.
Experiment 2. Effects of adrenalectomy on the EFS- induced potentiation of
cocaine-induced reinstatement. In this experiment we examined the effect of
adrenalectomy on reinstatement following exposure to EFS prior to administration
of low-dose cocaine, similar to the experimental setup seen in experiment 1. Six rats
were tested for the role of elevated corticosterone in EFS-induced potentiation of
cocaine-induced reinstatement. After acquiring stable self- administration, rats
underwent bilateral adrenalectomy (ADX) under ketamine/xylazine anesthesia and
were implanted with a subcutaneous 25% corticosterone (Sigma-Aldrich) pellet in
the nape of the neck. This treatment results in plasma corticosterone concentrations
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similar to those found at the nadir of the diurnal cycle, thus maintaining normal
diurnal corticosterone fluctuations while eliminating evoked increases (Mantsch
and Katz 2007). The rats received 0.025% corticosterone in the drinking water
(ethanol concentration = 0.0001%). During the active phase, when most drinking
occurs, this treatment results in plasma corticosterone concentrations similar to
those observed at the circadian peak (Mantsch and Katz 2007). Drinking water also
contained 0.9% NaCl. Upon recovery, rats underwent extinction training, followed
by reinstatement testing. Each rat was tested for reinstatement four times in a
counterbalanced sequence (once with each treatment: EFS + saline; EFS + cocaine
(2.5 mg/kg, ip); CTRL + saline; CTRL + cocaine (2.5 mg/kg, ip)). Consecutive tests
were separated by additional extinction sessions.
Experiment 3. Effects of corticosterone on cocaine-seeking following
administration of low-dose cocaine. In order to better understand the role of
corticosterone in EFS effects in, we examined the effect of administration of stress
level corticosterone on cocaine-induced reinstatement. After extinction training,
adrenal- intact rats (n = 6) were tested for reinstatement following an injection of
corticosterone (2.0 mg/kg, ip) or vehicle (0.03% EtOH, ip) 40 min prior to
administration of cocaine (2.5 mg/kg, ip) or saline. This dose of corticosterone
reproduces EFS- induced plasma levels (Table 1) as measured using RIA (see
below). Each rat was tested four times in a counterbalanced sequence (once with
each treatment: vehicle + saline; vehicle + cocaine; CORT + saline; CORT + cocaine)
with consecutive tests separated by additional extinction sessions.
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Experiment 4. Effects of RU38486 on corticosterone-induced potentiation of
cocaine-induced reinstatement. To test the role of GR in corticosterone-induced
potentiation of reinstatement, adrenal-intact rats (n = 10) received an injection of
RU38486 (12.5 mg/kg, sc) or vehicle (45% hydroxypropyl -cyclodextrin) one hour
prior to administration of corticosterone (2 mg/kg, ip) or vehicle (0.03% ethanol).
Forty minutes later, rats were tested for cocaine-induced reinstatement (2.5 mg/kg,
ip). Each rat was tested 4 times in a counterbalanced sequence (once with each
treatment: RU486 + Vehicle + cocaine; RU486 + CORT + cocaine; Vehicle + Vehicle +
cocaine; Vehicle + CORT + cocaine), with consecutive tests separated by additional
extinction sessions. In order to confirm that the dose of RU38486 used activated GR
in the brain (Spiga, Knight et al. 2010), translocation of GR was measured using
immunofluorescence.
Immunofluorescence. Previously adrenalectomized rats anesthetized with
ketamine/xylazine/acepromazine (77/1.5/1.5 mg/ml/kg; ip) were transcardially
perfused with 0.05 M PBS, followed by 4% paraformaldehyde in 0.1 M PB. Brains
were removed, postfixed and cryoprotected as previously described (Gasser,
Orchinik et al. 2009). Coronal sections (30 μm) containing the dentate gyrus were
immunostained using an antibody directed against GR (Santa Cruz Biotechnology,
SC-1004 Lot:D0309). After rinsing in PBS containing 0.3% Triton X-100 (PBST),
sections were rinsed, mounted onto SuperFrost microscope slides, dried and
coverslipped with Vectashield medium (Vector Laboratories, Burlingame, CA).
Photomicrographs were acquired using a Retiga 2000R digital camera (QImaging,
Surrey, BC, Canada) on a Nikon 80i microscope using NIS Elements software (Nikon
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Instruments, Melville, NY).
Experiment 5. Effects of corticosterone on high dose cocaine-induced
reinstatement. In order to determine if administration of corticosterone could
potentiate the reinstatement effect of other doses of cocaine that do reinstate when
given alone, we performed an experiment similar to that described in experiment 3
using a high dose of cocaine. Following extinction training, adrenal intact rats (n=9)
received an injection of corticosterone (2.0 mg/kg, ip) 40 minutes prior to an
injection of high dose cocaine (10 mg/kg, ip) (Mantsch and Goeders 1999) or saline.
Each rat was tested twice in a counterbalanced sequence, once with each treatment
(CORT+cocaine, CORT+saline).
Corticosterone assay. To determine the effects of experimental manipulations on
plasma corticosterone concentrations, rats (n = 7) were subjected to the treatments
in experiments 1-4 and 6, and blood samples were collected at time points
corresponding to the beginning of self-administration. The plasma was isolated
from the samples and corticosterone concentrations were determined using a
commercial RIA kit (MP Biochemicals, Irvine, CA). RIA is used to measure the
concentration of hormone molecules using a radioactive label that quantifies the
amount of hormone by determining the extent to which it binds with a commercially
produced antibody against corticosterone. The kit uses a limited amount of the
specific antibody that reacts with corticosterone labeled with a tritium isotope.
Upon addition of an increasing amount of corticosterone, a correspondingly
decreasing fraction of radiolabeled corticosterone added is bound to the antibody.
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Results
The rats used in these studies acquired stable self-administration in 9  1.2
days, and reached extinction criteria in 8.4  0.8 days. There was no significant
difference in responding across all groups on either the last day of selfadministration (121  8 responses/session) or the last day of extinction (11  1
responses/session). The effects of experimental manipulations on rat plasma
corticosterone concentrations are shown in table 1. Both the corticosterone
injection and EFS treatment resulted in significantly elevated corticosterone
concentration when compared to a vehicle injection. Plasma corticosterone levels in
the corticosterone treated group were not significantly different from levels seen
following exposure to EFS.
Experiment 1. Effects of stress on cocaine-seeking following administration of
low-dose cocaine. Exposure to EFS prior to administration of a subthreshold dose
of cocaine results in reinstatement behavior not seen with injection of low-dose
cocaine itself. Figure 5 shows the effects of exposure to EFS and systemic
administration of a low dose of cocaine (2.5 mg/kg) given alone as well as in
combination to intact rats. Data are shown as reinstatement of responding on the
active lever. A repeated measures one-way ANOVA revealed that there is a
significant main effect of treatment on active lever responding in this cohort
(p<0.01). Post hoc comparisons demonstrate that neither treatment with the lowdose of cocaine, nor exposure to EFS, resulted in an increase in active lever
responding when compared to saline controls (Figure 5). There was however, a

63
significant effect in animals receiving low-dose cocaine in combination with
exposure to EFS (Newman-Keuls, p<0.05).

Figure5. Effects of EFS on cocaine-induced reinstatement in intact rats. Data
represent mean  SEM of active lever responding over a 2 hour period following
exposure to 15 minutes of uncontrollable, intermittent electric footshock (EFS) or
no shock (CTRL) followed by administration of cocaine (2.5 mg/kg, ip) or saline.
N=7; * p0.05 compared to all other conditions.

Experiment 2. Effects of adrenalectomy on the EFS-induced potentiation of
cocaine-induced reinstatement. EFS produced significant increases in plasma
corticosterone levels (table 1). In order to determine if EFS-induced increases in
corticosterone contributed to the EFS-induced potentiation of reinstatement, the
effects of adrenalectomy were examined. Adrenalectomy treatment blocked the
EFS-induced potentiation of cocaine-induced reinstatement seen in the prior
experiment. In adrenalectomized rats, a repeated measures one-way ANOVA
showed there is no main effect of treatment on active lever responding (p>0.10) as
was seen in intact rats. Similar to what was seen in intact rats, neither exposure to
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EFS alone nor administration of low dose cocaine (2.5 mg/kg) alone led to a
significant increase in responding on the active lever. Furthermore, in ADX rats, EFS
did not potentiate low dose cocaine-induced reinstatement of active lever
responding (Figure 6). This is in contrast with the effect seen in intact animals
receiving the same treatment conditions.

Figure 6. Effects of EFS on cocaine-induced reinstatement in adrenalectomized rats.
Data represent mean  SEM of active lever responding over a 2 hour period
following exposure to 15 minutes of uncontrollable, intermittent electric footshock
(EFS) or no shock (CTRL) followed by administration of cocaine (2.5 mg/kg, ip) or
saline. N=6; * p0.05 compared to all other conditions.
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Vehicle
Cocaine (2.5
mg/kg)

Control

EFS

122  28
129  32

265  57 *
244  47*

Corticosterone Normetanephrine
(2.0 mg/kg)
(2.5 mg/kg)
384  34*
93  16
360  46*

Table 1. The effects of experimental conditions on plasma corticosterone
concentrations. The table shows corticosterone concentrations (mean  SEM)
measured in the plasma of drug naïve rats (n=7) that had received the indicated
treatments. Rats were subjected to each of the treatments and blood samples were
recovered at a time point consistent with the initiation of reinstatement testing.
Data were analyzed by one-way ANOVA with Bonferroni multiple comparisons posthoc analysis. * p0.05.

Experiment 3. Effects of corticosterone on cocaine-seeking following
administration of low-dose cocaine. Since adrenalectomy prevented the EFSinduced potentiation of reinstatement, the ability of corticosterone, at a dose that
reproduces EFS-induced increases, was tested for its ability to potentiate cocaineinduced reinstatement. As seen in table 1, the dose of corticosterone chosen (2.0
mg/kg; i.p.) caused an increase in plasma corticosterone similar to that seen
following exposure to EFS. Administration of corticosterone alone was sufficient to
potentiate cocaine-induced reinstatement in a similar manner to EFS, resulting in
reinstatement with a dose of cocaine that does not reinstate when given alone.
Responding during reinstatement testing in rats treated with either cocaine or
saline with or without a pretreatment of corticosterone can be seen in figure 7.
Repeated measures one-way ANOVA reveals a significant main effect of treatment
on active lever responding (p<0.0001). Post hoc comparisons reveal that neither
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administration of low dose cocaine nor corticosterone alone was capable of
inducing significant reinstatement as measured by active lever responding when
compared to vehicle/saline treated control animals. There was however, significant
reinstatement seen in animals that received an injection of low dose cocaine
following a pretreatment with corticosterone (Newman-Keuls, p<0.01).

Figure 7. Effects of corticosterone treatment on basal and cocaine-primed
reinstatement. Rats (n=6) received an injection of corticosterone (CORT; 2.0 mg/kg,
ip) or vehicle, 40 minutes prior to an injection of cocaine (2.5 mg/kg, ip) or saline.
Data represent mean  SEM of active lever responding over a 2-hour period
following administration of cocaine or saline. Significant increases in responding
were observed only in animals that received both corticosterone and cocaine. *
p0.01 compared to all other conditions.

Experiment 4. Effects of RU38486 on corticosterone-induced potentiation of
cocaine-induced reinstatement. Administration of the GR antagonist, RU38486
(12.5 mg/kg), failed to block the corticosterone-induced potentiation of cocaineinduced reinstatement. Active lever responding in cocaine-primed animals treated
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with either corticosterone or vehicle with or without a pretreatment of RU38486 is
shown in figure 8. All of the animals in this cohort were administered low-dose
cocaine. Repeated measures one-way ANOVA revealed a main effect of treatment
(p<0.001) on active lever responding. Post hoc comparisons indicate that
responding on the active lever during reinstatement testing was significantly
greater in animals that received an injection of corticosterone prior to
administration of low-dose cocaine when compared to animals that received a
vehicle injection prior to cocaine (Newman-Keuls, p<0.01). Active lever responding
was also significantly greater when animals received both RU 38486 and
corticosterone injections prior to administration of cocaine (Newman-Keuls,
p<0.01). There was no significant difference in active lever responding in animals
treated with RU 38486 alone prior to low dose cocaine injection when compared to
animals treated with vehicle prior to cocaine.
In order to determine whether the dose of RU38486 used in this study
resulted in activation of central GR, immunoflourescence was used to examine the
location of GR. Once activated, GR translocates to the nucleus and as shown in figure
8B, GR (in red) is predominantly located in the nucleus following administration of
RU38486 (12.5 mg/kg, sc) indicating that our peripheral treatment resulted in GR
binding in the brain.
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Figure 8. Effects of the glucocorticoid receptor antagonist RU38486 and
corticosterone treatment on cocaine-induced reinstatement. (A) Rats (n=10) were
given an injection of RU38486 (12.5 mg/kg, sc) or vehicle 60 minutes prior to an
injection of corticosterone (2.0 mg/kg, ip) or vehicle. This was followed 40 minutes
later by an injection of cocaine (2.5 mg/kg, ip). Data represent mean  SEM of active
lever responses over a 2-hour period following the final injection. Significant
increases in responding were seen in animals which received corticosterone and
cocaine, regardless of RU38486 pretreatment. * p0.05 compared to saline/coc and
RU38486/coc conditions. (B) Photomicrograph of GR immunofluorescence in the
dentate gyrus of ADX rats treated with vehicle (top) or RU38486 (bottom).
RU38486 induced nuclear translocation of GR. Scale bar = 25 m

Experiment 5. Effects of corticosterone on high dose cocaine-primed
reinstatement. In order to determine the ability of corticosterone to potentiate
reinstatement induced by suprathreshold doses of cocaine, we examined the effect
of corticosterone pretreatment on a high dose of cocaine (10 mg/kg, i.p.). No
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difference was seen between the animals receiving corticosterone and those
receiving the high dose of cocaine alone. Figure 9 shows active lever responses
during reinstatement testing in rats treated with cocaine, with or without a
corticosterone pretreatment. t-test reveals no effect of treatment (p0.05)
suggesting the effect of corticosterone in non-additive, but rather acts to potentiate
the effects of cocaine.

Figure 9. Effects of corticosterone on high dose cocaine-induced reinstatement.
Rats (n=9) received an injection of cocaine (10 mg/kg, ip) 40 minutes after receiving
an injection of corticosterone (2.0 mg/kg, ip) or saline. Data represent mean  SEM
of active lever responding over a 2-hour testing period following the final injection.
No significant effect was seen between the two groups. p0.05.

Discussion
While it has long been recognized that stress plays a significant role in
addiction and relapse, the mechanism is not well understood. The results of these
experiments demonstrate that stress is capable of acting as a stage setter, allowing
stimuli that would not normally result in reinstatement or relapse behavior to do so
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when exposure occurs under a period of stress. This is in agreement with previous
work demonstrating the possibility of stress acting as a stage setter (Feltenstein and
See 2006; Buffalari and See 2009). The data show that rats that have consumed
cocaine under low-intake (short access) conditions do not reinstate when exposed
to a footshock stress alone. This footshock stressor will, however, potentiate
reinstatement when challenged with a low dose of cocaine (2.5 mg/kg) that will not
otherwise result in reinstatement. Further support for the potentiation effect is
demonstrated by the lack of an effect when corticosterone is given prior to
administration of high-dose cocaine. This demonstrates the lack of an additive
effect, suggesting corticosterone potentiates the effect of low dose cocaine. The
potentiation effect of footshock can be blocked through elimination of escalation of
adrenal hormones in response to stress. The effect can also be mimicked by
administration of corticosterone at a dose that produces similar blood levels as
those seen following exposure to a stressor. Of great interest to us, this effect of
corticosterone is not blocked when given in the presence of the glucocorticoid
receptor antagonist RU38486, suggesting that what we are seeing is independent of
GR activation.
Stress-induced reinstatement has been an area of great interest due to the
findings that reinstatement is only seen in a small range of treatment conditions
(Epstein, Preston et al. 2006). Our lab has demonstrated that reinstatement in
response to footshock is only seen in rats with a history of excessive drug-intake
(long access), but not in rats with restricted intake (short access) (Mantsch, Baker et
al. 2008). The data presented here confirm the lack of reinstatement in ShA animals
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following exposure to footshock, but also demonstrate the ability of footshock to
potentiate reinstatement in response to a non-reinstating dose of cocaine. These
data suggest that stress may act to increase an individual’s susceptibility to
reinstatement by increasing the sensitivity to other triggers, instead of acting as a
trigger itself.
The ability of footshock to potentiate cocaine-induced reinstatement in ShA
animals appears to be dependent upon the elevation of corticosterone, which is not
the case with footshock-induced reinstatement seen in LgA animals where
reinstatement occurs even in adrenalectomized rats (Erb, Shaham et al. 1996; Graf,
Hoks et al. 2011). In studies performed here, footshock was not able to potentiate
reinstatement in rats that had undergone adrenalectomy with corticosterone
replacement. Additionally, we have shown the effect of stress could be mimicked by
administration of corticosterone at a dose that matched blood concentrations seen
following footshock exposure. This suggests the effect of adrenalectomy is due to a
loss of corticosterone and not other stress-responsive adrenal hormones, such as
epinephrine and indicates that acute manipulations of corticosterone levels
immediately prior to reinstatement testing indicate a possible mechanism through
stress may increase susceptibility to cocaine-induced reinstatement.
It should be noted that these findings differ from previous studies in which
intravenous administration of corticosterone alone resulted in reinstatement of
drug seeking (Deroche, Marinelli et al. 1997). This study, however, differed in route
of corticosterone delivery (intravenous vs. ip), formulation of corticosterone used,
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as well as the experimental setup used. Our results are, however, consistent with
previous demonstrating that corticosterone administration increased the
reinforcing effects of the psychostimulant amphetamine (Piazza, Maccari et al.
1991) suggesting that while future work needs to be done in order to gain a better
understanding, there is justification for the differences seen.
In order to further test the ability of stress level corticosterone to potentiate
the effect of cocaine on reinstatement, we repeated this experiment with a high dose
of cocaine (10 mg/kg, ip). Under these conditions we were not able to see any
potentiation effect as we did with the subthreshold dose of cocaine. This, however,
was not unexpected, as this dose of cocaine has been repeatedly shown to cause
robust reinstatement. This suggests that the effect of corticosterone on
reinstatement is not additive, but rather is able to potentiate the effects of cocaine to
a point of reinstatement. It is possible that once a reinstatement threshold is
reached, as is the case with administration of high dose cocaine alone,
corticosterone has minimal effects on reinstatement behavior.
The potentiation of cocaine-induced reinstatement seen in our studies was
not blocked with the pretreatment of the GR antagonist RU38486. This suggests
that the stage setting effects of corticosterone we observed are not acting through a
GR-dependent mechanism. This is of interest as multiple studies have shown the
importance of GR at different stages of self-administration, but no work has been
done in isolating the role of GR in rapid effects of stress on reinstatement
(Ambroggi, Turiault et al. 2009).
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The dose of RU38486 used (12.5 mg/kg, ip) was able to permeate the CNS
and bound GR in the brain. The dose used is lower than what has been
demonstrated to cause inhibition of a large percentage of GR (Spiga, Knight et al.
2011), but we were able to demonstrate the effectiveness of a lower dose. We were
able to show the translocation of labeled GR to the nucleus in adrenalectomized rats,
lacking any endogenous corticosterone. This demonstrated the ability of RU38486
to not only access the brain, but also interact with the majority of GR. It is important
to note, however, that administration of RU486 may have other effects not
accounted for in these studies. Along with its interactions with GR, RU486 also acts
on the progesterone receptor with great affinity as well as the androgen receptor
with lower affinity. RU486 does not, however, have any affinity for MR (Cadepond,
Ulmann et al. 1997).
Recent work has shown a number of mechanisms through which
glucocorticoids function independently of GR activation (Groeneweg, Karst et al.
2011). We propose that exposure to stress, and the resulting increase in plasma
corticosterone levels, sets the stage for increased sensitivity to other known triggers
of reinstatement. This is occurring through a GR-independent mechanism and at a
relatively rapid time scale. Furthermore, it can be speculated that the site of action
in the brain involves the NAc and/or the PFC as these are regions involved in
reinstatement circuitry and appear to be required for cocaine-induced
reinstatement (McFarland and Kalivas 2001). The work presented in the following
chapters aims at gaining a better understanding of the mechanism behind this effect
as well as the site of action responsible.
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III. ROLE OF SITE SPECIFIC DOPAMINE IN CORTICOSTERONE-INDUCED
POTENTIATION OF COCAINE-INDUCED REINSTATEMENT

Introduction
Previously, as seen in chapter 1, we have demonstrated the ability of stress to
act as a stage setter, potentiating reinstatement behavior caused by another
stimulus, such as acute cocaine treatment. We have shown that exposure to electric
footshock (EFS) prior to administration of a sub-threshold dose of cocaine results in
the reinstatement of cocaine seeking behavior. We then demonstrated that this
footshock-induced effect was dependent upon glucocorticoid activity and could be
mimicked with systemic administration of corticosterone. Finally, we showed that
this potentiation effect was working through a non-glucocorticoid receptor (GR)
mediated mechanism, as administration of the GR antagonist RU38486 did not block
reinstatement. These data suggest that stress and glucocorticoid activity are able to
potentiate cocaine-induced reinstatement by acting as a stage setter, making the
individual susceptible to reinstatement in response to triggers such a sub-threshold
dose of cocaine. The work done in the following experiments aims at gaining a
better understanding of the neurobiological processes involved in the behavior we
have observed, including the brain regions involved in mediating this behavior as
well as the downstream mechanisms responsible.
It has been well established that cocaine seeking, both reinstatement and

75
reinforcement, involves activation of the mesocorticolimbic dopamine system (Wise
and Rompre 1989; Kalivas and McFarland 2003; Pierce and Kumaresan 2006). This
circuit involves cell bodies originating the VTA and projecting to regions such as the
PFC and the NAC among others (Kalivas and McFarland 2003; Wise 2004).
Inactivation of this system through the use of GABA agonists administered directly
into the VTA, PFC or NAc prevents the cocaine-primed reinstatement that can be
seen following a period of cocaine self-administration (McFarland and Kalivas
2001). More specifically, administration of dopamine or dopamine agonists directly
into the NAC or the PFC is sufficient to cause reinstatement of drug seeking (Self,
Barnhart et al. 1996; De Vries, Schoffelmeer et al. 1999; Cornish and Kalivas 2000;
McFarland and Kalivas 2001). Additionally, dopamine antagonists have been shown
to block the rewarding properties of cocaine (De Wit and Wise 1977) as well as
block cocaine-induced reinstatement when administered into the NAc prior to a
systemic injection of cocaine (10 mg/kg i.p.) (Madayag, Kau et al. 2010). These data
suggest a key role for the NAC, as well other regions involved in the mesolimbic
dopamine system, such as the PFC, in reinstatement. Here we examined the role of
both the NAc and PFC in order to determine the region or regions involved the
corticosterone-dependent, stress-induced, potentiation of cocaine-induced
reinstatement we observed in chapter 1.
The role of the NAc in reinstatement of cocaine seeking has further been
examined in order to understand the contributions of its subdivisions, the core and
the shell. It has been demonstrated that drugs of abuse, such as cocaine, will
stimulate dopamine activity in the NAc shell, as measured with in vivo microdialysis
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(Pontieri, Tanda et al. 1995; Cadoni and Di Chiara 1999). The elevation of dopamine
in the NAc shell appears to be dependent upon corticosterone release. Prevention of
corticosterone release through adrenalectomy blocks cocaine induced increased in
NAc shell dopamine, resulting in dopamine levels similar to those seen in the NAc
core, and the effect that can be brought back with corticosterone replacement
(Barrot, Marinelli et al. 2000).
Cocaine will also be self-administered directly into the NAc shell, but not the
core (Rodd-Henricks, McKinzie et al. 2002). Disruptions of the NAc core, however,
have been shown to have other effects such as impaired pavlonian learning
(Parkinson, Willoughby et al. 2000; Hall, Parkinson et al. 2001) as well cocaineseeking (Ito, Robbins et al. 2004). Additionally, administration of dopamine
agonists into the NAc core resulted in greater reinstatement compared to
administration into the NAc shell (Schmidt, Anderson et al. 2006; Schmidt and
Pierce 2006). Dopamine antagonists block cocaine-induced reinstatement when
administered into the NAc shell and block reinstatement as a result of dopamine
agonists when administered to either region (Bachtell, Whisler et al. 2005).
Considering the exact role of these subdivisions in reinstatement of drug seeking is
still a subject of debate, we examined both subdivisions in an effort to determine the
region of interest for the results seen previously.
In addition to the role of the NAc in reinstatement, there is evidence that stress
is capable of increasing dopamine levels in the NAc. Exposure to a brief episode of
electric footshock has been shown to result in elevations in dopamine concentration
when measured in the NAc (Kalivas and Duffy 1995). Electric footshock as well as
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restraint stress has also been shown to elevate dopamine levels in the PFC by an
even greater extent than the NAc (Abercrombie, Keefe et al. 1989; Imperato, PuglisiAllegra et al. 1989).
Some evidence suggests that glucocorticoids may contribute to this effect
(Marinelli, Piazza et al. 1994; Rouge-Pont, Marinelli et al. 1995). In these studies,
inhibition of corticosterone synthesis by administration of metyrapone, blunted the
ability of cocaine to elevate dopamine levels in the NAc. Additionally, it has been
demonstrated that administration of the glucocorticoid receptor antagonist,
RU38486, into the lateral ventricle, significantly attenuates stress-induced
elevations in PFC dopamine, suggesting this effect is dependent upon glucocorticoid
receptors (Marinelli, Aouizerate et al. 1998; Butts, Weinberg et al. 2011).
These findings, in combination with data demonstrating that dopamine
agonists or administration of dopamine itself in the NAc and PFC is sufficient to
cause reinstatement, led us to examine the role of dopamine in the corticosteronedependent, stress-induced potentiation of reinstatement described in chapter 1
(Wise, Murray et al. 1990; Self, Barnhart et al. 1996; De Vries, Schoffelmeer et al.
1999; Cornish and Kalivas 2000).
In the present study, we examined the site of action involved in corticosteronedependent potentiation of cocaine-induced reinstatement. To do this we
administered corticosterone directly into the NAc or PFC prior to administration of
a low-dose of cocaine to examine the effect on reinstatement. We also examined
dopamine levels within the NAc following administration of corticosterone and lowdose cocaine to determine the role of dopamine in the reinstatement behaviors we
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have observed. In addition, we used site-specific delivery of a dopamine antagonist,
fluphenazine, in order to determine if dopamine activity in the NAc (core or shell) or
PFC was required for the behavior we observed. We propose that the
corticosterone-induced potentiation of cocaine-induced reinstatement involves
dopaminergic activity within the NAc and PFC and the experiments done in this
chapter will help to gain a better understanding of this behavior.

Materials and Methods
Animals. Male Sprague-Dawley rats (Harlan Laboratories, Inc., St Louis, MO),
weighing 275-325 g, were housed individually in a temperature- and humiditycontrolled, AAALAC-accredited vivarium under a 12h/12h reversed light- dark cycle
(lights off at 0700 h) with ad libitum access to food and water. Procedures were
carried out in accordance with the NIH Guide for the Care and Use of Laboratory
Animals.
For experiments 1 and 3, the reinstatement of extinguished cocaine seeking
was examined. These experiments used the methods described below.
Jugular catheterization. Rats received indwelling jugular catheters under
ketamine/xylazine (100 mg/kg; 2 mg/kg, ip) anesthesia as previously described in
chapter 2(Mantsch, Baker et al. 2008; Graf, Hoks et al. 2011). Lines were connected
to syringe pumps (Razel, Stamford, CT) via fluid swivels (Instech Lab. Inc., Plymouth
Meeting, PA) suspended above the chambers. Swivel/leash assemblies were
balanced to permit unrestrained movement.
Cocaine self-administration, extinction and reinstatement. Self-administration
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was conducted using computer- interfaced operant conditioning chambers
contained in sound-attenuating cubicles (Med Associates, St. Albans, VT). Following
recovery from surgery, rats were trained to self-administer cocaine (0.5 mg/kg/200
μl, iv) by pressing a lever under a fixed ratio one schedule during daily 2-h sessions.
Cocaine infusions were accompanied by illumination of a light followed by a 25-s
time out period during which the light was extinguished but the lever remained
extended. Responding on a second, inactive lever was also recorded. Once stable
responding was observed ( <10% variation in daily responding over 3 consecutive
sessions) rats underwent an additional 14 days of daily self-administration prior to
a period of extinction training consisting of daily sessions during which the cocaine
solution was replaced with saline. Once extinction criterion was met ( 10 active
responses/session across 3 sessions), each rat was tested for reinstatement.
Reinstatement sessions were identical to extinction except that they were preceded
by the delivery of an experimental treatment (e.g. intracranial injection) and then
the administration of a low dose of cocaine (or saline). Reinstatement was defined
as an increase in responding on the lever previously reinforced by cocaine
compared to the preceding extinction session. Inactive lever pressing was recorded
during reinstatement but is not reported due to a lack of significant effects.
Experiment 1. Effects of site-specific corticosterone delivery on cocaine
seeking following low-dose cocaine administration. In order to determine the
site of action involved in corticosterone-induced potentiation of cocaine-induced
reinstatement, we attempted to reproduce the potentiation of cocaine-induced
reinstatement seen with systemic corticosterone or EFS via site-specific delivery of
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corticosterone. At the time of jugular implantation, rats received bilateral 11 mm,
26-gauge cannula aimed at the PFC or NAc for intracranial injections. The tips of the
cannulae were aimed 0.5 mm above the target region and the following coordinates
were used (Paxinos and Watson 1998): (NAc core: A/P: +1.0, M/L:  2.2, D/V: -6.5 at
0) (NAc shell: A/P: +2.5, M/L:  0.75, D/V: -6.5 at 0) (prelimbic division of the PFC:
A/P: +2.5, M/L:  1.0, D/V: -3.5 at 8 angle). Following SA and extinction training,
rats were tested under five different treatment conditions. Rats were given an
intracranial injection of corticosterone (HBC corticosterone was used to avoid the
need to solubilize in EtOH; 0.05 g/side over 1 min) followed fifteen minutes later
by an injection of cocaine (2.5 mg/kg, ip shown to be subthreshold for
reinstatement) or saline immediately before reinstatement testing which was done
in an identical manner as described in previous chapter. Rats were also were also
tested for the effects of fluphenazine on cocaine-induced reinstatement as will be
discussed in experiment 3. Histological analysis of the brains was performed
following the completion of testing in order to confirm the placement of cannulae.
Experiment 2. Effects of corticosterone on cocaine-induced extracellular
dopamine in the NAc. In order to examine the effects of corticosterone on cocaineinduced elevations in extracellular dopamine levels, drug-naïve rats under
ketamine/xylazine anesthesia were implanted with bilateral guide cannulae (20
gauge; 14 mm; Plastics One) directed at the nucleus accumbens, using the following
coordinates (Paxinos and Watson 1998): +0.9 mm AP, ± 2.5 mm ML to bregma, -4.4
mm from the surface of the skull, at an angle 6° from vertical, and allowed to recover
for 5 days. The night before testing, rats were housed in self-administration
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chambers. The following day, microdialysis probes constructed as previously
described (Baker, McFarland et al. 2003) were inserted into guide cannulae and
dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM MgCl2, and
0.15% PBS, pH 7.4) was pumped through at a rate of 1l/min for 3 h to allow
neurotransmitter levels to stabilize. Samples were collected at 20 min intervals
throughout the study. After baseline samples were collected, rats received an
injection of corticosterone (2.0 mg/kg ip; n = 13) or vehicle (0.03% EtOH; n = 12)
followed, 40 min later, by an injection of cocaine (2.5 mg/kg ip). Samples were
collected for an additional 2 h. After the study, rats were anesthetized with an
overdose of pentobarbital (60 mg/kg ip) and transcardially perfused with 0.9%
saline and 2.5% formalin. Brains were removed, postfixed and sectioned in the
coronal plane (100 μm) for verification of probe placement.
Dopamine concentrations were quantified by comparing peak heights from samples
and external standards using HPLC coupled to electrochemical detection. The
mobile phase consisted of 15% acetonitrile, 10% methanol, 150 mM NaH2PO4, 4.76
mM citric acid, 3 mM SDS, and 50 M EDTA, pH 5.6. Dopamine was separated using
a reverse-phase column (3 m; 80 X 3.2 mm; ESA) and detected using an ESA
Coulochem II detector coupled to two electrodes set at -0.075 V and +0.25 V,
respectively.
Experiment 3. Effects of site-specific dopamine receptor antagonism on the
corticosterone-induced potentiation of cocaine seeking. In order to determine
the brain regions involved in the effects seen as well as the role of dopamine in
these effects, rats were given an injection of corticosterone (2.0 mg/kg, ip) or
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vehicle (10% ETOH) followed 25 minutes later by an intracranial injection of the
dopamine D1/D2 receptor antagonist fluphenazine (30 nmoles/side in 0.3 l
injection over 1 minute) or vehicle (aCSF) and followed fifteen minutes later by an
injection of cocaine (2.5 mg/kg, ip) and the start of reinstatement testing. All
treatments were given in a counterbalanced sequence. Consecutive tests were
separated by additional extinction sessions.

Results
Experiment 1. Effects of site-specific corticosterone delivery on cocaine
seeking following low-dose cocaine administration. The potentiating effect of
systemic corticosterone administration on cocaine-induced reinstatement was
reproduced by corticosterone delivery directly into the NAc. As seen in table 1,
there was no significant difference in reinstatement between animals in which the
NAc shell was targeted in comparison to animals in which the NAc core was targeted
(p>0.05). For this reason the data from these two groups were combined and
presented as a single data set. A 2-way repeated measures treatment condition x
reinstatement ANOVA showed a significant overall effect of treatment condition
(Intra-NAc Veh vs. ip Coc/Intra-NAc Cort vs. ip Coc/Intra-NAc Cort + ip Veh;
F2,22=4.460; p<0.05) and reinstatement condition (reinstatement test session vs.
previous extinction session; F1,11=7.374; p<0.05) and a significant treatment x
reinstatement interaction (F2,22=4.182; p<0.05).

Post-hoc testing showed that

neither intra-NAc corticosterone in combination with ip saline nor low-dose cocaine
in combination with intra-NAc vehicle produced significant reinstatement.
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However, when rats received intra-NAc corticosterone prior to cocaine
administration, significant reinstatement was observed (2-tailed t11=3.132 vs.
extinction; p<0.05).
Direct injection of corticosterone into the PFC also resulted in the potentiation
of cocaine-induced reinstatement. A 2-way repeated measures treatment condition
x reinstatement ANOVA showed a significant main effect of reinstatement
(F1,5=8.022; P<0.05), but not treatment.

Significant reinstatement x treatment

interaction (F1,10=4.137; P<0.05). Post-hoc testing showed significant reinstatement
only in the group receiving intra-PFC corticosterone + ip cocaine.

A

B

Figure 10. Site-specific administration of
corticosterone. (A) Administration of corticosterone directly into the NAc results in
the potentiation of cocaine-induced reinstatement. (B) Similar potentiation effects
were seen in rats in which corticosterone was administered directly into the PFC.
Data represent mean SEM of active lever responding over a 2 hr period following
administration of intracranial administration of corticosterone (0.05 g/side) or
vehicle, followed 15 minutes later by administration of cocaine (2.5 mg/kg; ip) or
vehicle. * p<0.05 compared to all other conditions.
The accuracy of intra-NAc and intra-PFC injections is shown in Figure 11.
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Figure 11. Representation of cannulae placement into PFC (A) and PFC (B). All rats
in which cannulae that were not directed at the target brain region were not used in
the data analysis. Corrdinates relative to bregma.

Extinction

Intra NAc
Veh+ ip
cocaine

Intra NAc
corticosterone + ip
cocaine

Intra NAc
corticosterone + ip
saline
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NAc

9.66  1.7

17.71  6.47

26.16 6.4

15.28 5.06

8.33  1.7

8  3.94

15.66  4.77

8  1.98

Shell
NAc
Core

Table 2. Breakdown of responses during reinstatement testing in rats in which NAc
shell and NAc core were targeted (mean  SD). A 3-way reinstatement (extinction
vs. reinstatement test) x treatment (ip cocaine + intra-NAc corticosterone, ip cocaine
+ intra-NAc vehicle, ip veh + intra-NAc corticosterone) x NAc subregion (core vs
shell) failed to show a significant main effect of reinstatement site or significant
interactions between the site and treatment, site and reinstatement, or site,
treatment and reinstatement. Thus, data from the NAc core and shell were
combined for all analyses.
Experiment 2. Effects of corticosterone pretreatment on cocaine-induced
increases in extracellular dopamine in the NAc. Figure 12 illustrates
extracellular dopamine levels in the NAc before and after a systemic injection of
cocaine (2.5 mg/kg, ip) in animals pretreated with either corticosterone (2.0 mg/kg,
ip) or vehicle. Corticosterone pretreatment potentiated elevations in NAc
extracellular dopamine levels following administration of a low dose of cocaine. A
2-way ANOVA with pretreatment as a between-subjects factor and time (sample) as
a repeated measure showed no significant interaction. However, cumulative post
cocaine extracellular dopamine levels (calculated as areas under the curve using all
post-cocaine samples) were significantly higher in corticosterone- than in vehiclepretreated animals (unpaired t-test; t(23)=1.793, p=0.043).
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Figure 12. In vivo microdialysis measuring dopamine levels in the NAc. Samples
taken in the first 60 min were used as baseline, followed by an injection of either
CORT (2.0 mg/kg, i.p) or vehicle. 40 min later all animals received an injection of
cocaine (2.5 mg/kg, i.p) and samples were collected for an additional 160 min.
Inset: Dopamine area under the curve (AUC) for the 2-h period following cocaine
injection.

Experiment 3. Effects of site-specific dopamine receptor antagonism on the
corticosterone-induced potentiation of cocaine seeking. In order to determine
if increases in NAc or PFC DA were required for potentiated reinstatement in rats
that received ip corticosterone prior to administration of a low dose of cocaine. Rats
were given the non-selective DA receptor antagonist, fluphenazine, into the NAc
(n=13) or PFC (n=7) prior to reinstatement testing. Fluphenazine delivery into the
NAc attenuated reinstatement. A 2-way repeated measure pretreatment condition
(fluphenazine vs. vehicle) x reinstatement (ip cort + coc vs. extinction) ANOVA
showed significant overall effects of fluphenazine pretreatment (F1,12=4.629;
p=0.05) and reinstatement (F1,12=8.708; p<0.05) and a significant fluphenazine x
reinstatement interaction (F1,12=6.007; p<0.05)(figure 13). Cocaine administration
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following corticosterone delivery reinstated cocaine seeking following intra-NAc
pretreatment with vehicle (2-tailed t12=3.259; p<0.01 vs. extinction) but not
fluphenazine. Furthermore, cocaine seeking following fluphenazine was
significantly reduced compared to intra-NAc vehicle pretreatment (2-tailed
t12=2.406; p<0.05).

A

B

Figure 13. Effects of fluphenazine on cocaine-induced reinstatement following
pretreatment with corticosterone. Data represent mean  SEM of active lever
responding over a 2 hour period following administration of corticosterone (2.0
mg/kg; ip) followed 25 minutes later by (A) intra-NAc or (B) intra-PFC fluphenazine
(30 nmoles/side) or vehicle, followed 15 minutes later by cocaine (2.5 mg/kg; ip).
(A)* p<0.01 compared to extinction. # p<0.05 compared to intra-NAc veh. N=13. (B)
* p<0.02 compared to extinction. # p<0.001 compared to intra-PFC veh. N=7.

Discussion
The role of stress in cocaine addiction and reinstatement has been well
established, but the exact mechanism through which it exerts its effects is still
unknown. Recent studies have suggested that, in some situations, stress may act as
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a stage setter, allowing stimuli that normally do not result in reinstatement to do so
under periods of stress (Feltenstein and See 2006; Buffalari and See 2009). We have
shown in chapter 1 that rats with a history of cocaine intake under ShA (2
hours/day) conditions show a potentiation of cocaine-induced reinstatement when
exposed to electric footshock or acute systemic corticosterone administration prior
to reinstatement testing. These data demonstrated a role of corticosterone in the
potentiation of reinstatement with a low-dose cocaine primer, however the site of
action was not determined.
Here we demonstrate that corticosterone can act in for both the NAc and the
PFC in the corticosterone-induced potentiation of cocaine-induced reinstatement.
Like systemic corticosterone delivery, administration of corticosterone directly into
either the NAc or PFC potentiates cocaine-induced reinstatement when rats are
challenged with a dose of cocaine unable to trigger reinstatement when given alone.
While various studies have demonstrated a differential role for the NAc core and
shell in reinstatement (Anderson, Bari et al. 2003; Anderson, Schmidt et al. 2006;
Schmidt, Anderson et al. 2006), the studies performed here showed no significant
difference between the two regions.
Previous research has demonstrated that extinguished drug seeking can be
reinstated with priming injections of either indirect or direct dopamine receptor
agonists (Gerber and Stretch 1975; de Wit and Stewart 1981; Wise, Murray et al.
1990). Localization studies have gone on to show that these effects are mediated, at
least in part, by the NAc as well as other areas of the mesocorticolimbic dopamine
system (Stewart and Vezina 1988; McFarland and Kalivas 2001; Wise 2008). Based
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on these findings we examined extracellular dopamine concentrations in the NAc
following systemic administration of corticosterone prior to an injection of low-dose
cocaine.
Cocaine-induced elevations in extracellular dopamine levels within the brain
appear to dependent upon the release of corticosterone. Blockade of corticosterone
synthesis or release prevents cocaine-induced dopamine increases and the effect
can only be brought back when corticosterone is replaced (Marinelli, Piazza et al.
1994; Barrot, Marinelli et al. 2000). This would suggest that corticosterone is
responsible, or at least required, for dopamine concentrations to increase in the
brain in response to cocaine administration.
Here we have shown the ability of corticosterone to potentiate cocaineinduced dopamine elevations. The effects of corticosterone treatment on
extracellular dopamine concentration in the NAc were measured using in vivo
microdialysis. We have found that the potentiation in dopamine levels was very
similar to the effect we saw on reinstatement suggesting that corticosterone
potentiates cocaine-induced reinstatement in part by modulating dopaminergic
neurotransmission in the NAc. This is in agreement with previous studies showing
that acute stress (Kalivas and Duffy 1995) or corticosterone treatment (Marinelli,
Piazza et al. 1994; Barrot, Marinelli et al. 2000) can elevate extracellular dopamine
concentrations in the NAc. Future studies will also need to be done in order to
determine the role of dopamine in other regions of the mesocorticolimbic dopamine
system, especially the PFC.
Since corticosterone potentiated cocaine-induced increases in NAc dopamine,
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we next decided to determine if this potentiated dopamine response was involved in
the potentiation of cocaine-induced reinstatement. In these studies, we have shown
that the potentiation effect of i.p. corticosterone can be blocked with pretreatment
with the non-specific dopamine receptor antagonist fluphenazine into the NAc or
PFC. This suggests a requirement for dopamine activity in the NAc and PFC in order
to cause the behavioral effects observed. A role for dopamine is not surprising, as
elevations of dopamine in these regions have been shown to be involved in
reinstatement by numerous studies (Wise, Murray et al. 1990; Self, Barnhart et al.
1996; McFarland and Kalivas 2001).
The findings that corticosterone potentiates cocaine-induced increases in NAc
dopamine taken together with the data showing blockade of the dopamine receptor
in this region as well as the PFC prevents reinstatement suggests that
corticosterone’s ability to influence dopamine concentrations is what is responsible
for this behavior. This is in agreement with previous studies showing that
dopamine receptor activation is sufficient to reinstate drug seeking and the
magnitude of cocaine-induced increases in NAc dopamine plays a key role in the
magnitude of reinstatement (Cornish and Kalivas 2000; Bachtell, Whisler et al.
2005; Schmidt, Anderson et al. 2006; Madayag, Kau et al. 2010). Additionally,
administration of dopamine antagonists directly into the NAc can block cocaineinduced reinstatement in response to a reinstating dose of cocaine, especially when
administered into the NAc shell (Anderson, Bari et al. 2003; Bachtell, Whisler et al.
2005; Anderson, Schmidt et al. 2006).
In addition to the findings suggesting the role of the NAc in the reinstatement
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of cocaine seeking, the PFC has also been strongly implicated in these behaviors. It
has been shown that administration of dopamine itself into the PFC can enhance
cocaine-induced reinstatement and administration of the dopamine antagonists into
the PFC can prevent reinstatement (McFarland and Kalivas 2001; Sanchez, Bailie et
al. 2003). Furthermore, it has been shown that administration of cocaine directly
into the PFC can increase cocaine seeking, and this effect can be blocked with
dopamine antagonists (Park, Bari et al. 2002). Additionally, stress and
corticosterone can also increase dopamine levels in the PFC, possibly to an even
greater extent than occurs in the NAc (Abercrombie, Keefe et al. 1989). Together
these findings support our results suggesting inhibition of dopamine activity within
the PFC, as well as the NAc, can alter reinstatement of cocaine seeking.
It is important to note, however, that the role of the infralimbic vs. prelimbic
areas of the PFC were not examined in this study. Recent findings suggest an
opposing role of these regions in the reinstatement of cocaine seeking. In
agreement with the data presented here, previous work has demonstrated that
inhibition of the prelimbic cortex will block reinstatement of drug seeking in
response to cue, drug priming and stress-induced cocaine seeking (McFarland and
Kalivas 2001; Capriles, Rodaros et al. 2003; McLaughlin and See 2003; McFarland,
Davidge et al. 2004). In opposition to this, it has been shown that inhibition of the
infralimbic cortex can induce cocaine seeking in extinguished rats (Peters,
LaLumiere et al. 2008). The opposing roles of the subdivisions of the PFC may be
due to involvement of different circuitry or expression levels of the different
dopamine receptors, both issues that are not addressed by the work presented here
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(Kebabian and Greengard 1971; Gaspar, Bloch et al. 1995; Caine, Negus et al. 2000).
In the studies shown here only the prelimbic cortex was targeted for direct
administration and further studies would need to be performed in order to
determine the role of these two regions in the behaviors seen here.
The results of these experiments suggest that increases in corticosterone
during stress may augment the dopamine response to appetitive stimuli, such as
cocaine. Without this dopamine response, corticosterone-induced potentiation of
cocaine seeking is not observed, as is seen following administration of fluphenazine.
Additionally, site-specific administration of corticosterone directly into the NAc and
PFC demonstrates that these regions play a key role in the behavior we have
observed here as well as in chapter 1. These findings suggest a mechanism through
which corticosterone influences dopamine concentrations in order to regulate
reinstatement behavior, however, additional work needs to be done in order to
better understand the exact mechanism through which corticosterone is acting to
regulate dopamine levels (see chapter 3).
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IV. ROLE OF ORGANIC CATION TRANSPORTER 3 IN CORTICOSTERONE –
INDUCED POTENTIATION OF COCAINE-INDUCED REINSTATEMENT

Introduction
Glucocorticoid hormones have been implicated in the mechanism through
which stress may regulate drug use and relapse. Multiple studies have
demonstrated the ability of glucocorticoids to influence all aspects of addiction
related behaviors, including acquisition, maintenance and reinstatement of cocaine
seeking (Deroche, Marinelli et al. 1997; Mantsch and Goeders 1999; Shalev,
Marinelli et al. 2003; Mantsch, Baker et al. 2008). The ability of glucocorticoids to
significantly influence reinstatement, however, is still not entirely understood.
Previous studies have shown the ability of acute stressors to modulate cue-induced
reinstatement, but the mechanism behind this effect has not been extensively
studied (Feltenstein and See 2006; Buffalari and See 2009). In the experiments
performed here, we examined a potential mechanism through which glucocorticoid
activity may modulate reinstatement behavior.
The experiments described in chapters 1 and 2, demonstrated that stress and
acute corticosterone administration can potentiate cocaine-induced reinstatement
through a mechanism that is not dependent upon glucocorticoid receptor (GR)
activation, since the GR antagonist, RU38486, does not block corticosterone-
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potentiated reinstatement. Additionally, in agreement with previous studies, we
have shown that this effect involves corticosterone-mediated elevations in
dopamine levels within the NAc and PFC, brain regions implicated in reinstatement
(Abercrombie, Keefe et al. 1989; Imperato, Puglisi-Allegra et al. 1989). The goal of
the experiments performed here is to examine the mechanism through which
corticosterone can regulate dopaminergic neurotransmission and, thereby,
reinstatement.
Many of the actions of glucocorticoids can be attributed to activation of GR
and resulting alterations in gene transcription and translation. However, many of
the acute, rapid effects of glucocorticoids have been shown to act through
mechanisms that act independently of GR activation, such as endocannabinoid or
nitric oxide activity (Di, Maxson et al. 2009; Pasricha, Joels et al. 2011). The acute
effects of stress occur in a rapid time course, suggesting alterations in gene
transcription and translation may not be involved. One such mechanism by which
glucocorticoids may rapidly influence drug seeking is through inhibition of
monoamine clearance by organic cation transporter 3 (OCT3). OCT3 is a high
capacity transporter involved in the extracellular clearance of dopamine as well as
other monoamines (Grundemann, Liebich et al. 1999). This transporter has a lower
affinity for monoamines than the primary, uptake 1 transporters suggesting that it
may act as a secondary clearance mechanism (Simmonds and Gillis 1968; Iversen
and Salt 1970). Additionally, OCT3 mediated clearance is inhibited by
corticosterone through a GR-independent mechanism (Grundemann, Liebich et al.
1999). It has also been demonstrated that the concentration of corticosterone
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needed to inhibit OCT3 mediated transport falls within physiological stress levels
(Gasser, Lowry et al. 2006; Hill, Makky et al. 2011).
Previous work has shown OCT3 to be expressed throughout the brain,
including regions involved in the regulation of drug seeking behavior, including the
NAc and PFC (Cui, Aras et al. 2009; Gasser, Orchinik et al. 2009). Numerous studies
have demonstrated the importance of dopamine activity in these regions as it
relates to reinstatement of cocaine seeking (Self, Barnhart et al. 1996; De Vries,
Schoffelmeer et al. 1999; Cornish and Kalivas 2000). Additionally, it has been
shown that glucocorticoids are capable of elevating extracellular dopamine
concentrations in the NAc (Rouge-Pont, Marinelli et al. 1995; Piazza, Rouge-Pont et
al. 1996) and the PFC (Butts, Weinberg et al. 2011). Notably, in Chapter 2 we
demonstrated that corticosterone-induced effects on DA in both regions is
necessary for the potentiation of cocaine-induced reinstatement. While these data
demonstrate the ability of increased dopamine levels to result in reinstatement and
show that stress and glucocorticoids are involved in the regulation of dopamine
levels, the exact mechanism behind dopamine elevations remains unknown.
Previous studies have demonstrated that glucocorticoids may be involved in the
reduction of dopamine clearance (Gilad, Rabey et al. 1987). In this study,
administration of a synthetic glucocorticoid, methylprednisolone, decreased
dopamine clearance as measured by a dopamine uptake study. Here we suggest that
corticosterone-induced blockade of OCT3, a high capacity, low affinity clearance
mechanism, may act to set the stage for other triggers to increase dopamine
concentrations to levels that could result in reinstatement (see figure 12). The aim
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of these studies is 1) examine the expression of OCT3 in the NAc in relation to
dopamine terminals thus positioning it as a viable dopamine clearance mechanism
in this region; and 2) to determine whether blockade of OCT3 by a nonglucocorticoid inhibitor mimics the potentiating effects of stress and corticosterone
on reinstatement by low-dose cocaine.

Materials and Methods
Animals. Male Sprague-Dawley rats (Harlan Laboratories, Inc., St Louis, MO),
weighing 275-325 g, were housed individually in a temperature- and humiditycontrolled, AAALAC-accredited vivarium under a 12h/12h reversed light- dark cycle
(lights off at 0700 h) with ad libitum access to food and water. Procedures were
carried out in accordance with the NIH Guide for the Care and Use of Laboratory
Animals.
Experiment 1. OCT3 immunoreactivity in the NAc. The expression of OCT3
within the NAc was examined in order to better understand its role within this
region. Drug-naïve rats were anesthetized with ketamine/xylazine/acepromazine
(77/1.5/1.5 mg/ml/kg; ip) and were transcardially perfused with 0.05 M PBS,
followed 4% paraformaldehyde in 0.1 M PBS. Brains were removed, postfixed and
cryoprotected as previously described (Gasser, Orchinik et al. 2009). Coronal
sections (30 m) containing the NAc were immunostained using antibodies directed
against OCT3 (Isolated from rabbit; OCT31A; ADI, San Antonio, TX) and tyrosine
hydroxylase (TH; MAB 318, Millipore, Billerica, MA). After rinsing in PBS containing
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0.3% Triton X-100 (PBST), sections were incubated overnight with anti-OCT3
antibody (1:250) and anti-TH antibody (1:1600) in 0.1% PBST. Sections were
rinsed and incubated 2 hours with AlexaFlour594-conjugated donkey anti-rabbit
and AlexaFlour488-conjugated donkey anti-mouse IgG antibodies (1:200;
Invitrogen). Sections were rinsed, mounted onto SuperFrost microscope slides,
dried and coverslipped with Vectasheild medium (Vector Laboratories, Burlingame,
CA). Photomicrographs were acquired using a Retiga 2000R digital camera
(QImaging, Surrey, BC, Canada) on a Nikon 80i microscope using NIS Elements
software (Nikon Instruments, Melville, NY).
Experiment 2. Effects of the non-glucocorticoid inhibitor, normetanephrine,
on low-dose cocaine-induced reinstatement. To examine the role of OCT3 in the
potentiation of reinstatement, rats received indwelling jugular catheters under
ketamine/xylazine (100 mg/kg; 2 mg/kg, ip) anesthesia as described in Chapter 1,
and were trained to self-administer cocaine (0.5 mg/kg/200 μl, iv) by pressing a
lever under a fixed ratio one schedule during daily 2-h sessions. Once stable
responding was observed ( <10% variation in daily responding over 3 consecutive
sessions) rats underwent an additional 14 days of daily self-administration prior to
a period of extinction training consisting of daily sessions during which the cocaine
solution was replaced with saline as previously described in earlier chapters. Once
extinction criterion was met each rat was tested for reinstatement. Reinstatement
sessions were identical to extinction except that they were preceded by the delivery
of an experimental treatment (e.g. injection of normetanephrine or vehicle) and
then the administration of a low dose of cocaine (or saline). Reinstatement was
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defined as an increase in responding on the lever previously reinforced by cocaine
compared to the preceding extinction session. Inactive lever pressing was recorded
during reinstatement but is not reported due to a lack of significant effects.
Following reinstatement and extinction, rats (n=10) were pretreated with
the OCT3 inhibitor normetanephrine (2.5 mg/kg, ip) or vehicle (saline) 40 minutes
prior to receiving an injection of cocaine (2.5 mg/kg, ip) or saline, and testing for
reinstatement. Each rat was tested four times in a counterbalanced sequence (once
with each treatment: Vehicle + saline; Vehicle + cocaine; normetanephrine + saline;
normetanephrine + cocaine). Consecutive tests were separated by additional
extinction sessions.
Results
Experiment 1. OCT3 immunoreactivity in the NAc. The presence of OCT3-like
immunoreactivity (OCT3-ir) was examined within the NAc in order to determine its
ability to act as a transporter within this region. OCT3-like immunoreactivity was
observed as puncta distributed throughout the NAc core and shell, and was also
concentrated in small diameter (6-8 m) perikarya (figure 14). Staining was not
observed in sections incubated in the absence of the OCT3 antibody. In both
regions, OCT3-ir puncta were observed in close proximity to tyrosine hydroxylaseimmunoreactive fibers. This positions OCT3 to potentially serve as a clearance
mechanism within this region.
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Figure 14. Photomicrograph of dual-label immunoflourescence for OCT3 (red) and
tyrosine hydroxylase (green) in the nucleus accumbens. Punctate OCT3-like
immunoreactivity was observed throughout the nucleus accumbens, and was
concentrated in close proximity to TH-immunoreactive fibers. Left=40X,
Right=100X. Scale bar= 50m.

Figure 15. OCT3 inhibition enhances cocaine-induced reinstatement. Animals
received vehicle or the OCT3 inhibitor normetanephrine (nm, 2.5 mg/kg, ip),
followed by a low dose of cocaine (2.5 mg/kg) or vehicle. Normetanephrine
potentiated low-dose cocaine-induced reinstatement. (Repeated measures ANOVA
with Tukey post hoc test. * indicates p<0.05 compared to veh and nm 2.5 groups).
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Experiment 2. Effects of the non-glucocorticoid inhibitor, normetanephrine,
on low-dose cocaine-induced reinstatement. In order to test the hypothesis that
corticosterone-induced blockade of OCT3 contributes to the potentiation of cocaineinduced reinstatement, rats were tested for cocaine-induced reinstatement
following administration of the non-glucocorticoid OCT3 inhibitor,
normetanephrine. Figure 15 illustrates responding during reinstatement testing in
rats treated with cocaine or saline in the presence or absence on the nonglucocorticoid OCT3 inhibitor normetanephrine. Repeated measures one-way
ANOVA revealed a significant main effect of treatment on active lever responding
(p<0.01). Post-hoc comparisons indicated that neither normetanephrine nor lowdose cocaine treatment alone significantly increased active lever responding
compared to the vehicle-treated condition,. However, active lever responding was
significantly increased over all other conditions when animals had received both
normetanephrine and cocaine (Newman-Keuls, p<0.01). These results are similar to
the data previously reported following administration of corticosterone or EFS prior
to a low-dose of cocaine.

Discussion
The role of stress in cocaine addiction and reinstatement has been
extensively studied, but the mechanisms involved remain largely unknown. It has
been demonstrated that glucocorticoids have the capability to elevate dopamine
levels within the NAc and PFC and that increases in dopamine activity within this
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region is key for reinstatement behavior (Rouge-Pont, Marinelli et al. 1995; Piazza,
Rouge-Pont et al. 1996; Self, Barnhart et al. 1996; De Vries, Schoffelmeer et al. 1999;
Cornish and Kalivas 2000; Butts, Weinberg et al. 2011). In the earlier chapters we
have shown that corticosterone potentiates cocaine-induced reinstatement through
a GR-independent mechanism that involves the elevation of dopamine levels in the
NAc. Glucocorticoids are known to be able to alter neurotransmission through a
number of GR-independent mechanisms (Di, Maxson et al. 2009; Groeneweg, Karst
et al. 2011), and we propose that corticosterone potentiates cocaine actions on
reinstatement behavior and dopamine levels through inhibition of OCT3-mediated
dopamine clearance.
Here we have confirmed previous studies demonstrating the expression of
OCT3 in the NAc (Gasser, Orchinik et al. 2009), and have demonstrated that OCT3-ir
is in close proximity to cells containing tyrosine hydroxylase, the enzyme
responsible for converting tyrosine to l-DOPA, the precursor to dopamine. This
suggests that OCT3 is not only in areas of the brain important for reinstatement
behavior, but very likely has an interaction with dopamine within this region.
Further work needs to be done in order to determine the phenotype of OCT3expressing cells within this region. Localization within astrocytes as opposed to
neurons could allow a single transporter to interact with a number of synapses,
magnifying the decrease in clearance when inhibited. Additionally, the localization
of OCT3 would give further insight as to the proximity to dopamine receptors which
may also regulate the effectiveness of the transporter.
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Additionally, we have shown that administration of normetanephrine, the Omethylated metabolite of norepinephrine and potent inhibitor of OCT3 (Martel,
Ribeiro et al. 1999), can potentiate the effects of a subthreshold dose of cocaine on
reinstatement while having no effect when administered alone. This is in agreement
with previous studies showing that peripherally administered normetanephrine
could enhance acute venlafaxine-induced increases in PFC norepinephrine
concentrations (Rahman, Ring et al. 2008). The results of our studies suggest that
the behavioral effects of stress and corticosterone may be, at least in part, mediated
by the inhibition of OCT3-mediated dopamine clearance within the NAc. Further
work may need to be done, however, to confirm the role of OCT3 as
normetanephrine has also been reported to act as a weak antagonist at -adrenergic
receptors (Langer and Rubio 1973). This action may in itself alter cocaine seeking
in a manner that could confound the results seen here (Lee, Tiefenbacher et al.
2004). In order to further examine the role of OCT3, future studies will need to be
done using a viral knockdown approach or a genetic knockout model. The use of
these approaches would allow to us to examine behavior in an animal lacking any
OCT3-mediated clearance and avoid the potential non-specificity of pharmacological
inhibitors. Further work will also need to be done to explore the impact of other
GR-independent, rapid glucocorticoid effects, including the role of he
endocannabinoid system, which is also activated by elevated corticosterone levels.
Examination of these other systems will aid in determining the exact role of OCT3
mediated clearance.
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Taken together with previous data demonstrating corticosterone-induced
potentiation of the effects of cocaine on reinstatement behavior, the data shown
here suggest that inhibition of OCT3 may act to set the stage for later reinstatement.
Both corticosterone and normetanephrine inhibit OCT3, a high capacity, low-affinity
monoamine clearance mechanism, and this inhibition may make the system
susceptible to elevations in dopamine as a result of another trigger, such as a low
dose of cocaine. This would account for why administration of corticosterone or
inhibition of OCT3 alone does not result in reinstatement as OCT3 may only be
playing a significant role in clearance when the primary transporters (such as DAT)
are saturated (see figure 4). Inhibition of OCT3 during periods of DAT saturation
may lead to the elevation of the magnitude, duration and physical spread of
dopamine (Grundemann, Schechinger et al. 1998). Based on these results we
propose that blockade of OCT3-mediated monoamine clearance may represent a
novel mechanism through which stress can influence the reinstatement of cocaineseeking behavior.
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V. ROLE OF CORTICOSTERONE AND OCT3 IN COCAINE-INTAKE DEPENDENT
NEUROPLASTICITY

Introduction
The primary obstacle in the treatment of drug addiction is the unpredictable
relapse that can occur even after prolonged periods of abstinence. The chronically
relapsing nature of addiction is likely attributable to some level of neuroplasticity
that occurs in an intake dependent manner following prolonged periods of excessive
drug use. Evidence of this intake dependent neuroplasticity can be seen by altered
sensitivity of rats exposed to various levels of cocaine to reinstatement. Rats
provided long access (LgA; 6 hrs/day) exposure to cocaine, but not rats given short
access (ShA; 2 hrs/day), escalate their drug use (Ahmed and Koob 1998) and show
emergent or augmented reinstatement in response to stressors (Mantsch, Baker et
al. 2008), cues (Kippin, Fuchs et al. 2006), and administration of a cocaine primer
(Mantsch, Yuferov et al. 2004; Knackstedt and Kalivas 2007; Mantsch, Baker et al.
2008) compared to ShA rats, while having no effect on SA or extinction levels (figure
18). This altered susceptibility to reinstatement suggests that cocaine selfadministration (SA) produces long-term intake-dependent neuroadaptations that
can alter relapse vulnerability in response to a variety of stimuli. Gaining a greater
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understanding of 1) the nature of the intake-dependent neuroplasticity that
contributes to heightened relapse and drug use and 2) the mechanisms through
which this neuroplasticity is put in place may aid in the advancement of treatment
for cocaine addiction.
Another adaptation seen following excessive cocaine intake is an increase in
CRF-induced reinstatement. Direct administration of the neuropeptide CRF into the
brain results in the reinstatement of cocaine seeking (Erb, Petrovic et al. 2006;
Mantsch, Baker et al. 2008). CRF also mediates stress-induced reinstatement as
reinstatement can be blocked with pretreatment of CRF receptor antagonists prior
to exposure to the stressor (Erb, Shaham et al. 1998; Graf, Hoks et al. 2011). Like
reinstatement to other stimuli, CRF-induced reinstatement is augmented in LgA rats
(Mantsch, Baker et al. 2008). Notably, in one key site, the VTA, delivery of CRF will
only reinstate in rats with a history of LgA cocaine SA (Blacktop, Seubert et al.
2011). The actions of CRF in the VTA are likely due to increases in dopamine
concentrations as it has been reported that administration of CRF to the VTA
increases VTA dopamine cell firing (Wanat, Hopf et al. 2008) as well as stimulates
dopamine-related behaviors, such as drug seeking (Wang, Shaham et al. 2005).
Additionally, EFS-induced reinstatement in LgA rats is blocked following
administration of a dopamine receptor antagonist (Figueroa-Guzman, Mueller et al.
2011), suggesting that stress-induced reinstatement, which is CRF-dependent, likely
involves enhanced dopaminergic neurotransmission.
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The goals of this chapter are to 1) examine the potential role of augmented
dopamine neurotransmission due to the altered expression of OCT3 in augmented
reinstatement and 2) to determine if elevated corticosterone during SA also
represents a mechanism through which intake-dependent cocaine-induced
neuroplasticity is put into place, potentially via the monoamine transporter, organic
cation transporter 3 (OCT3).
To address the first goal, we examined the effect of both LgA and ShA cocaine
exposure on the expression of a specific monoamine transporter, OCT3.
Considering its role in regulating cocaine seeking, we hypothesized that intakedependent alterations in OCT3 expression following LgA SA could account for the
augmented reinstatement seen in these rats. OCT3 is a high capacity, uptake2
transporter involved in the clearance of dopamine as well as other monoamines and
is directly inhibited by corticosterone (Grundemann, Schechinger et al. 1998;
Grundemann, Liebich et al. 1999). Previous work we have done (chapters1-3)
suggests that OCT3 is involved in the regulation of extracellular dopamine levels and
inhibition of OCT3-mediated clearance may make an individual susceptible to
reinstatement to other triggers. Based on this work, we examined the expression of
OCT3 in both the NAc and PFC, regions known to be involved in the reinstatement of
drug seeking (Wise, Murray et al. 1990; Self, Barnhart et al. 1996; Vialou, Balasse et
al. 2008; Gasser, Orchinik et al. 2009). We propose that OCT3 expression may be
altered in animals undergoing LgA cocaine exposure compared to animals with ShA
exposure. This change in OCT3 expression may alter the ability to regulate
dopamine concentrations within the brain and may represent one example of

107
cocaine-induced neuroplasticity that could represent an explanation for the intake
dependent variations in reinstatement. OCT3 mRNA and protein levels will be
examined in both the NAc and PFC in animals exposed to LgA SA, ShA SA and saline
treatment.
In addition to acutely regulating cocaine seeking as demonstrated in chapter
2, there is much evidence that elevated corticosterone is critical for cocaine-induced
neuroadaptations. Surgical adrenalectomy prior to LgA SA slows escalation of
cocaine intake and attenuates the later reinstatement seen in intact rats (Mantsch,
Baker et al. 2008). Also, blockade of corticosterone synthesis with metyrapone
blocks cocaine-induced sensitization that occurs following repeated administration
of the drug (Piazza, Marinelli et al. 1996). This implicates the need for cocaineinduced elevations in glucocorticoids in order to establish the neuroplasticity
required for the augmentations in reinstatement behavior.
Elevations of corticosterone in response to cocaine SA vary depending on the
level of drug intake. ShA and LgA exposure to cocaine increase plasma
corticosterone to similar peak concentrations, however, LgA cocaine exposure
sustains this elevation for greater duration each SA day (Mantsch, Yuferov et al.
2003). These findings raise the possibility that the neuroplasticity responsible for
augmented reinstatement in LgA rats may be due to a prolonged elevation in
corticosterone levels.
Several studies have examined the role of hormonal stress responses in
addiction-related neuroplasticity (Kreek and Koob 1998; Koob and Kreek 2007).
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Our lab has demonstrated that the adrenal response is necessary at the time of SA in
order to establish the plasticity that is required to result in elevated cocaine seeking
(Mantsch and Katz 2007; Mantsch, Baker et al. 2008). It has also been discovered
that the elimination of cocaine-induced adrenal activity during SA prevents later
stress- and cocaine-induced sensitization (Rouge-Pont, Marinelli et al. 1995; Prasad,
Ulibarri et al. 1996; Przegalinski, Filip et al. 2000). Here we examine the role of
adrenal activity in later i.c.v. CRF- and footshock-induced reinstatement by
performing an adrenalectomy with corticosterone replacement (ADX/C) prior to 2
weeks of LgA cocaine SA. The reinstatement behavior of these rats was compared to
those in which ADX/C was performed following the SA period, allowing cocaineinduced plasticity to occur, but before extinction and reinstatement testing.
Previously, it has been demonstrated that cocaine-induced elevations in
corticosterone during LgA SA are necessary for the emergence of later augmented
cocaine-induced reinstatement (Mantsch, Baker et al. 2008). In this study, surgical
adrenalectomy with diurnal corticosterone replacement prior to, but not after
repeated (14 day) cocaine SA prevented the augmentation of reinstatement seen in
intact rats. This suggests that elevated corticosterone is necessary for the
establishment of neuroplasticity that leads to heightened relapse. Since it has been
previously shown that LgA SA also establishes the ability of EFS to reinstate and
augments reinstatement in response to CRF (Mantsch, Baker et al. 2008), the goal of
this experiment was to extend our previous findings showing corticosterone
involvement in increased cocaine-induced reinstatement to EFS and CRF. Future
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studies will need to be performed in order to examine the potential role of OCT3 in
the corticosterone effects.
Materials and Methods
Subjects
Male Sprague-Dawley rats (Harlan Laboratories, St. Louis, MO),
approximately 90 days old (325 g) were used. Rats were housed individually in a
temperature and humidity-controlled, AAALAC-accredited facility under a 12h/12h
reversed light cycle (lights off at 0700 hours) and had access to food and water at all
times.
Jugular catheterization.
Rats received indwelling jugular catheters under ketamine/xylazine (100
mg/kg; 2 mg/kg, ip) anesthesia as previously described in chapters 1-3. Lines were
connected to syringe pumps (Razel, Stamford, CT) via fluid swivels (Instech Lab.
Inc., Plymouth Meeting, PA) suspended above the chambers. Swivel/leash
assemblies were balanced to permit unrestrained movement.
Self-Administration and Extinction
Following recovery from surgery, rats were trained to self-administer
cocaine (1.0 mg/kg/inf, i.v., NIDA Drug Supply Program, Bethesda, MD) by pressing
a lever under an FR1 schedule during 2-hour sessions, within which the active lever
was extended into the chamber and the corresponding stimulus light was
illuminated. Pressing this lever resulted in a cocaine infusion (200 l over 5.0 s),
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followed by a 25 s period during which the stimulus light was extinguished, but the
lever remained extended. Inactive lever responding was recorded, but had no
programmed consequences. Once significant SA under the FR1 schedule was
observed (>10 infusions), the requirements for SA were gradually increased until
rats were self-administering under an FR4 schedule. After stable responding was
observed under the FR4 schedule (<10% variation from mean over three sessions),
rats underwent ADX/C or sham procedures and/or were provided access to cocaine
during 6-hour (long access) sessions for 14 days.
Experiment 1. Effects of cocaine SA on expression of OCT3. To examine intakedependent changes in the expression of OCT3 following exposure to cocaine, we
used both western blot and quantitative real time polymerase chain reaction
(qPCR). Rats received jugular catheters and after recovery from surgery, were
allowed to SA under with either long access (LgA, 6-hours daily) or short access
(ShA, 2-hours daily) exposure to cocaine. An additional group received only saline
for the 14 day testing period with all groups undergoing 10 days of extinction
testing under 2 hour conditions. Following SA and extinction, rats were sacrificed
and brains were dissected on ice. Tissue punches (2 mm in diameter) were
obtained from the NAc (core and shell) and PFC (Il and PrL), then immediately
frozen in dry ice and stored at -80C until the experiments were performed (see
figure 16).
Total RNA and protein were isolated from the punches using TRIzol reagent
(Life Technologies). Isolated RNA samples were quantified spectrophotometrically
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at 260 nm. RNA (1.2 g/reaction) was used for cDNA synthesis using Promega
Reverse Transcription System. To analyze OCT3 mRNA levels, quantitative PCR
was used with gene-specific primers (rOCT3 Sense: 5’- CCA CCA TGA GCC AGT TT 3’; rOCT3 Antisense- 5’-ACA CGA CAC CCC TGC CAC TA -3’). Real-time PCR
amplification reactions were performed with Quanta SYBR Green Fastmix Rox.
Reactions were run on an Applied Biosystem Step One Real Time PCR System
according to the manufacturer’s protocol.
Protein used for electrophoresis and western blot was also isolated using
TRIzol reagent. Protein concentrations were determined using the BCA protein
assay (Pierce, Rockford, IL). Approximately 25 g of protein was electrophoresed
on a tris-glycine SDS 10% polyacrylamide gel. Proteins were then electroblotted
onto polyvinyldine difluoride (PVDF) membrane (Invitrogen, La Jolla, CA) using a
semidry blotting apparatus. Membranes containing identical amounts of protein
were incubated for 1 hour in Tris-buffered saline containing 0.1% Tween-20
(TBST) and 5% nonfat dry milk. They were then rinsed and incubated overnight at
room temperature in TBST containing anti-OCT3 antiserum (Isolated from rat;
catalog No. OCT31-A, lot No. 401516A3.3; ADI; 1:1000 in 2% milk). After rinsing,
membranes were incubated for 1 hour in TBST containing secondary antibody
(horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG; 1:10000) and 2%
milk. Membranes were then rinsed and incubated with chemiluminescent substrate
(SuperSignal West Femto; Pierce) and digital images were captured. Bands
representing OCT3 were expected ~48-53 kD (Gasser, Orchinik et al. 2009). OCT3
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bands were compared to bands representing GAPDH in order to control for
variations in amount of protein loaded.

Experiment 2: Role of elevated corticosterone during LgA cocaine SA in the
augmentation of later reinstatement.
In these experiments we examined the effect of adrenalectomy on later
reinstatement to different stimuli in order to determine the role of corticosterone
during SA on later reinstatement.
Experiment 2A. Effects of adrenalectomy and corticosterone replacement on
footshock-induced reinstatement. To examine the potential role of
corticosterone in the establishment and expression of footshock-induced
reinstatement, rats underwent bilateral ADX via the dorsal approach under
ketamine and xylazine anesthesia and received corticosterone replacement (ADX/C)
(Mantsch and Katz 2007) before or after 14 days of cocaine SA or received sham
operations. Diurnal corticosterone replacement consisted of s.c. implantation of a
25% corticosterone (Sigma-Aldrich) pellet in the nape of the neck to produce blood
concentrations similar to those found at the nadir of the diurnal cycle along with the
inclusion of 0.025% corticosterone in the drinking water to emulate the circadian
peak observed during the active (dark) phase, within which most drinking occurs
(Jacobson, Akana et al. 1988). Pellets were made by melting a 1:3
corticosterone:cholesterol ration mixture over a flame and pouring it into a mold,
creating a 1.5 X 0.5 X 0.5 cm3 (l X w X h) pellet (Meyer, Micco et al. 1979).
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Corticosterone was dissolved in ethanol before introduction into the drinking water,
resulting in a final ethanol concentration of 1 ml/L (0.0001%). To replace depleted
sodium secondary to the loss of aldosterone as a result of ADX, drinking water for all
rats (ADX/C and sham) consisted of 0.9% NaCl solution. Corticosterone pellets
were replaced every seven days under sodium methohexital (1.5 mg, i.v.) sedation.
Sham rats were implanted with 100% cholesterol pellets. Sham operations were
identical to ADX surgeries, except that, once exposed, the adrenal glands were not
removed. Before undergoing ADX/C or sham procedures, rats were trained to selfadminister cocaine during 2 hour sessions. After recovery, rats were allowed to
self-administer again until stable patterns were re-established, at which time longaccess SA began, followed by extinction and testing for footshock-induced
reinstatement. A third group of rats were used to examine the effects of ADX/C after
SA, but before extinction on later footshock-induced reinstatement. These rats
underwent the ADX/C procedure after 14 days of SA and were allowed to recover
before the 10-day extinction period and reinstatement testing.
Experiment 2B. Effects of adrenalectomy with corticosterone replacement on
CRF- and EFS-induced reinstatement. ADX/C effects on reinstatement by i.c.v.
CRF were tested in a separate group of rats implanted with a cannula into a lateral
ventricle at the time of catheterization. Following recovery from surgery and SA
training, these rats underwent ADX/C or sham operations before SA and extinction.
After extinction, each rat was tested for reinstatement in response to two
concentrations of CRF and sterile water vehicle in counterbalanced sequence.
During the reinstatement testing rats received and i.c.v. 1-l infusion of CRF (0.5 or
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1 g; Sigma-Aldrich) or vehicle over a 1 minute period 15 minutes before placement
into chambers for 2 hours (Mantsch, Baker et al. 2008). A third group of rats
underwent ADX/C after 14-days of SA and, following a 3-4 day recovery period,
went through 10 days of extinction before testing for CRF-induced reinstatement. In
all cases, rats with confirmed injection sites outside the lateral ventricle were
excluded from data analyses.
To examine the role of the adrenal response in the establishment and
expression of footshock-induced reinstatement, rats underwent bilateral ADX under
ketamine and xylazine anesthesia and received ADX/C before or after 14 days of
cocaine SA or received sham treatments. All rats underwent SA training prior to
surgery and those receiving ADX/C prior to SA were allowed to recover from
surgery and demonstrate consistent lever-pressing behavior before beginning the
14-day SA period. Those receiving ADX/C post-SA, were allowed to recover from
surgery and then began extinction testing.
EFS testing was performed after extinction criteria had been met (<~10
responses/2 hr session). EFS was delivered through the stainless steel grid floors of
the SA chambers 15-min. prior to the 2 hr. testing session, which was otherwise
identical to extinction conditions. Shocks (0.5 mA, 0.5 seconds in duration) were
delivered an average of every 40 seconds, with a range of 10-70 second.
Reinstatement was defined as responding on the previously active lever and
compared to the preceding extinction session.

115
Measurement of Plasma Corticosterone
When possible, blood (100 l per sample) was acquired via the catheters for
the measurement of plasma corticosterone under basal conditions and during SA.
Samples were collected before (at 0800 hours, just after the start of the dark phase)
and after the 6-hour SA sessions (at 1400 hours) and at the corresponding baseline
time points. In addition, samples were acquired after 2 hours of SA (at 1000 hours)
and at the corresponding baseline time points from a separate group of rats for
examination of corticosterone at an earlier time during the SA sessions. The days on
which blood samples were taken varied across the 14-day test period such that
about half of the rats were sampled during the first seven days and the other half
during the final seven days of SA. In addition, 12 rats (six ADX/C and six sham)
implanted with a lateral ventricle cannula were used to examine the plasma
corticosterone responses to footshock and i.c.v. CRF. These rats underwent i.c.v.
cannula implantation and ADX/C or sham procedures before testing for footshockand CRF-induced corticosterone responses. Corticosterone was measured using
radioimmunoassay kits (MP Biomedicals, Irvine, CA). Blood was collected on ice in
tubes containing heparin and centrifuged to separate plasma, which was frozen at 80C. Samples were analyzed in duplicate.
Results
Experiment 1: Effects of cocaine exposure on OCT3 expression
Figure 16 illustrates the effects of cocaine SA (ShA and LgA) on the
expression of OCT3. qPCR was used to detect changes in mRNA levels and western
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blot was used to detect changes in protein measured after 10 days of extinction, a
time point that corresponds to that at which heightened reinstatement was
previously observed (Mantsch, Baker et al. 2008; Mantsch, Baker et al. 2008). Our
findings show that there is no statistically significant difference in mRNA expression
between rats exposed to either ShA or LgA SA conditions when compared to saline
controls (One–way ANOVA; NAc p=0.3443; PFC p=0.2963). Interestingly however,
there is a significant increase in OCT3 protein expression in the PFC in rats with a
history of LgA SA (One-way ANOVA with unpaired t-test; p=0.01). While there
appears to be a slight increase in OCT3 protein in the NAc in LgA, it is not
statistically significant (One-way ANOVA; p=0.6101).
A

C

B

D
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Figure 16. Effects of cocaine SA (ShA and LgA) on OCT3 mRNA and protein levels.
OCT3 mRNA levels in the NAc (A) and PFC (B) are expressed as a percentage
relative to saline controls. Data were analyzed using the CT method and are
represented as mean  SE. No statistically significant difference was found although
there is a trend suggesting cocaine exposure results in a decrease in OCT3 mRNA in
both regions examined. OCT3 protein examined using western blot analysis in the
NAc (C) and PFC (D). No statistically significant difference was found, although
there again appears to be a trend toward cocaine-dependent decrease in OCT3
protein in the PFC. A representative western blot showing a OCT3-ir band at ~48 kD
(E). Also shown: representation of punches taken from NAc (left) and PFC (right).
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Experiment 2: Role of elevated corticosterone during LgA cocaine SA in the
augmentation of later reinstatement.
SA-Induced increases in plasma corticosterone.
Figure 17 shows the SA-induced increases in plasma corticosterone in sham
treated and ADX/C rats. As we did not acquire samples from every rat in each group
at each time point, we used a 3 X 3 two-way independent measures ANOVA to
examine corticosterone at three time points corresponding to the times just before
SA testing (0800 hours), 2 hours into SA testing (1000 hours), and just after the 6
hour session (1400 hours) under basal conditions and in response to SA. The
ANOVA did not show a significant overall effect of time-of-day, although a clear
diurnal pattern of corticosterone fluctuation was observed under basal conditions in
sham treated rats with peak levels at 0800 hours corresponding to the start of the
dark phase, and the low point at 1400 hours, 6 hours into the dark phase. A
significant overall effect of treatment condition (baseline vs sham SA vs ADX/C SA;
F2,182=9.566; P<0.0001) and a significant treatment condition X time-of-day
interaction (F4,186=5.152; P<0.001) were observed. Comparison across treatments
using one-way ANOVA at each of the three times revealed significant main effects at
the 1000 hours (F2,30=3.850; P<0.05), but not the 0800 hours (pre-SA), time point.
Overall, corticosterone levels were significantly higher in sham-treated rats during
SA compared with basal conditions (P<0.001). SA-induced increases in
corticosterone were prevented by ADX/C treatment. Corticosterone levels were
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significantly reduced during SA in ADX/C rats compared with sham-treated controls
(P<0.05). By contrast, corticosterone levels in ADX/C rats during SA did not differ
from basal values in sham-treated rats. At the 1400 hours time point,
corticosterone levels in self-administering sham rats were also significantly higher
than that during sham baseline conditions (P<0.05). However, the difference
between sham and ADX/C SA rats at this time point did not reach statistical
significance.
Figure 18 demonstrates the effect of the three ADX/C conditions, sham
(n=28), rats that underwent ADX/C prior to LgA SA (n=30; pre-SA ADX) and those
who underwent ADX/C after LgA SA (n=24; post-SA ADX), on LgA SA as well as
extinction. Two-way ANOVA showed a significant overall main effect of SA day
(F13,1027=10.400; P<0.001) and ADX condition (F2,79=4.605; P<0.05), but did not
show a significant SA day x ADX condition interaction (Figure 18a). SA was
increased on days 4-14 compared to day 1 (P<0.05) and, overall, SA was slightly, but
significantly, reduced in rats that underwent ADX/C before SA compared with rats
that underwent ADX/C post-SA (P<0.05), but not when compared with sham
controls.
The effects of pre-SA ADX/C, post-ADX/C and sham treated animals is shown
in figure 18b,c. Two-way ANOVA showed significant main effects of extinction day
(repeated measure; F9,711=67.704; P<0.0001) and ADX condition (F9,79=7.29;
P<0.001), but no ADX condition x extinction day interaction. Overall, responding
was significantly lower in pre-SA ADX rats when compared to sham treated and
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post-SA ADX rats, suggesting that adrenal activity at the time of cocaine SA, but not
during extinction itself, contributed to drug-seeking behavior during the extinction
sessions.

Figure 17. Plasma corticosterone (CORT) (ng/ml  SE) measured at 0800 hours
(time corresponding to the start of daily SA session), 1000 hours ( time
corresponding to a point 2 hours into SA session), and 1400 hours (time
corresponding to completion of SA session) in sham-treated rats under basal
conditions (Sham Baseline) or during SA (Sham SA) or in ADX/C treated rats during
SA (ADX/C SA). In sham-treated rats, cocaine SA increased plasma corticosterone
relative to basal levels. During SA, ADX/C rats showed corticosterone levels that
were similar to baseline levels and significantly lower than levels during SA in
sham-treated rats (*P<0.001 vs sham baseline and ADX/C SA; **P<0.05 vs sham SA
only).
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Figure 18. Cocaine SA and extinction in sham and adrenalectomy with diurnal
corticosterone replacement (ADX/C)-treated rats. Data in (A) represent
intravenous cocaine SA (LgA; 6 hours/day) in rats that underwent adrenalectomy
and diurnal corticosterone replacement before 14 days of SA testing (pre-SA ADX/C;
n=30) or after 14 days of SA, but before extinction and reinstatement testing (postSA ADX/C; n=24) or underwent a sham treatment (n=28). Significant escalation of
SA was observed in all groups and, overall, SA was reduced in pre-SA ADX/C rats
relative to post-SA ADX/C, but not sham-treated rats (#p<0.05). Data in (B) and (C)
represent responding during extinction shown as daily responding during each of
the days of extinction (responses/2-hour session  SE; A) or total responding
collapsed across all 10 days ( SE; B). Overall, extinction responding was
significantly decreased in pre-SA ADX/C rats compared with either post-SA ADX/C
rat or sham-treated controls (*p<0.05; B).
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Experiment 2A. Effects of adrenalectomy and corticosterone replacement on
footshock-induced reinstatement.
We previously reported that EFS-induced reinstatement is established by
LgA SA. Here we examined the effects of ADX/C on footshock-induced
reinstatement in rats that underwent ADX/C before 14 days of long-access SA
(n=18), rats that underwent ADX/C after 14 days of SA, but before extinction and
reinstatement (N=15), and sham-treated rats (n=16), data shown in figure 19. A
two-way footshock reinstatement X ADX condition ANOVA that included rats from
all three ADX groups (sham, pre-SA ADX/C and post-SA ADX/C) showed significant
main effects of shock (F1,46=27.730; P<0.001) and ADX treatment (F2,46=3.768;
P<0.05) on cocaine seeking as well as a significant interaction between footshock
and ADX treatment (F2,46=3.231; P<0.05). Post hoc testing showed that significant
footshock-induced reinstatement occurred in sham-treated and post-SA ADX/C, but
not pre-ADX/C rats (P<0.05 vs extinction). Further, footshock-induced lever
pressing was significantly reduced in pre-SA ADX/C, but not post-SA ADX/C rats,
compared with sham controls (P<0.01), even though responding under extinction
conditions was not different.
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Figure 19. Responding during the reinstatement sessions preceded by 15 minutes
of intermittent electric footshock or during the preceding extinction session in preSA ADX/C (n=18), post-SA ADX/C (n=15) and sham-treated (n=16) rats following
LgA SA. Footshock-induced reinstatement was prevented by ADX/C before (pre-SA
ADX/C), but not after (post-SA ADX/C) LgA cocaine SA (*significant reinstatement,
P<0.05 vs extinction; #significant decrease vs sham, P<0.05).

Experiment 2B: Effects of adrenalectomy with diurnal corticosterone
replacement on CRF-induced reinstatement.
We have previously reported that, like footshock, reinstatement by i.c.v. CRF
is augmented after LgA SA (Mantsch, Baker et al. 2008). Figure 20, depicts the role
of adrenal activation at the time of earlier SA on later CRF-induced reinstatement.
The effects of ADX/C on CRF-induced reinstatement were examined in 12 rats that
underwent ADX/C before 14 days of SA, 9 rats that underwent ADX/C after 14 days
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of SA, but before extinction and reinstatement and 14 sham-treated rats. Two-way
CRF X ADX condition ANOVA showed significant main effects of CRF delivery (F2,60 =
5.396; P<0.01) and ADX condition (F2,30 = 3.382; P<0.05), but did not show a
significant CRF X ADX condition interaction. Post hoc testing showed overall dose dependent reinstatement by CRF, with significant reinstatement observed at the 0.5
g dose (P<0.05), but not the 1.0 g dose (P=0.058), when compared with vehicle
pretreatment. Overall, reinstatement was significantly reduced in the pre-SA ADX/C
group compared to the sham-treated group (P<0.05), but not in the post-SA ADX/C
group. To determine if CRF induced reinstatement in each of the ADX groups, a
planned analysis of reinstatement was conducted using one-way repeated measures
ANOVA within each ADX group. Significant dose-dependent CRF-induced
reinstatement was found in sham-treated (P<0.01) vs vehicle), but not pre- or postSA ADX/C rats.
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Figure 20. CRF-induced reinstatement in sham and ADX/C rats. Data shows
responding during the reinstatement sessions preceded by i.c.v. injections of CRF
(o.5 or 1 g) or vehicle in pre-self-administration (pre-SA) ADX/C (n=12), post-SA
ADX/C (n=9) and sham-treated (n=14) rats following LgA SA. Overall, CRF-induced
reinstatement was reduced by ADX/C before (pre-SA), but not after (post-SA) LgA
cocaine SA compares with sham-treated rats (*significant overall decrease vs sham;
P<0.05).

Discussion
Previous work demonstrated that LgA exposure to cocaine results in the
formation of addiction-related neuroplasticity. This can be seen in studies in which
rats with a history of LgA SA demonstrate augmented reinstatement in response to
cocaine (Mantsch, Yuferov et al. 2004; Knackstedt and Kalivas 2007; Mantsch, Baker
et al. 2008), EFS, CRF (Mantsch, Baker et al. 2008) and cues (Kippin, Fuchs et al.
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2006). The changes that result in the augmented vulnerability to reinstatement, as
well as how these changes are put into place, remain poorly understood. The
studies performed here aim to gain a better understanding of this process and the
mechanism responsible.
One potential mechanism that may explain the intake-dependent
neuroplasticity is alterations in expression of the monoamine transporter, OCT3.
OCT3 is a high capacity dopamine transporter that has been shown to be involved in
the regulation of cocaine seeking (see chapters 1-3). Earlier we showed that
inhibition of OCT3 expression could reduce dopamine clearance efficiency and may
result in an increase in susceptibility to reinstatement. We propose that cocaine
intake-dependent decreases in OCT3 expression may represent one mechanism
through which excessive cocaine intake alters later reinstatement.
Our results do not show any cocaine-induced reduction in OCT3 expression
in either the PFC or NAc as measured using qPCR (mRNA) or western blot (protein).
However, we did observe an increase in PFC protein expression following LgA SA,
but no change in NAc protein expression. As a corticosterone-sensitive transporter,
an increase in expression may have allowed for elevations in corticosterone to exert
a greater impact as more OCT3-mediated dopamine clearance would be inhibited,
which would be in agreement with the emergence of EFS-induced reinstatement in
LgA rats. However, ADX had no effect on cocaine-induced reinstatement in LgA rats
suggesting that a decrease in OCT3 expression may result in increased vulnerability
to escalations in dopamine as the secondary, uptake2-mediated clearance
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mechanism would be diminished. Our findings, however, were not consistent with
this hypothesis, suggesting that changes in OCT3 expression may not be involved in
cocaine intake-dependent neuroplasticity.
The work done here also examined the mechanism through which the intakedependent neuroadaptations occur. Previous reports have demonstrated that
administration of cocaine elevates plasma corticosterone levels (Moldow and
Fischman 1987; Mantsch, Yuferov et al. 2003; Mantsch, Cullinan et al. 2007). Here
we demonstrated that these cocaine-induced elevations of corticosterone are
prolonged in rats undergoing LgA SA. We then examined the role of these
corticosterone elevations in the formation of the intake-dependent neuroplasticity.
We examined the effect of adrenalectomy with diurnal corticosterone replacement
prior to cocaine SA or after SA, but prior to reinstatement testing, in order to
determine the role of corticosterone in the establishment of cocaine-induced
neuroplasticity. Our findings indicate that adrenalectomy prior to the start of SA
sessions slightly, but significantly alters cocaine intake and extinction and has
substantial influence on later reinstatement. It is important to note, however, that
sham treated animals had a slight decrease in SA that was not statistically
significant, suggesting that the surgical procedure itself may have some impact on
the behavior. Animals receiving the adrenalectomy prior to LgA SA do not exhibit
reinstatement behavior in response to EFS or ICV CRF compared to those receiving
adrenalectomy after LgA SA, but prior to reinstatement testing. This suggests that
increased corticosterone is required at the time of LgA SA, but not at the time of
reinstatement testing in order to produce the intake-dependent alterations in
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reinstatement. This is consistent with previous reports indicating that
adrenalectomy prior to LgA SA augments later cocaine-induced reinstatement
(Mantsch, Baker et al. 2008) as well studies showing adrenalectomy prior to
repeated stress blocks stressor-induced facilitation of cocaine SA (Goeders and
Guerin 1996; Mantsch, Saphier et al. 1998) and stressor-induced locomotor
sensitization (Rouge-Pont, Marinelli et al. 1995; Prasad, Ulibarri et al. 1998).
Together, these data indicate that elevations in corticosterone are involved in the
establishment of neuroplasticity that alters later behavioral responses, but are not
required at the time of stress-induced reinstatement.
One interesting finding in our experiments was the lack of effect of surgical
adrenalectomy post-SA, but prior to reinstatement testing. The results of the work
done in the previous chapters using ShA rats shows acute, stress-induced increases
in corticosterone at the time of reinstatement testing potentiate the reinstatement
response to other stimuli. In these studies corticosterone-induced OCT3 inhibition
appears to act as a stage setter, making the individual more susceptible to
reinstatement, however corticosterone itself is not mediating reinstatement. The
lack of a corticosterone requirement in LgA rats for reinstatement suggests that the
neuroadaptations that occur during LgA SA alter the system in such a way that acute
increases in corticosterone are not necessary. This, again, is another example for
why we examined the expression of OCT3 following excessive cocaine intake.
While our current findings strongly implicate a role for corticosterone in
cocaine intake-dependent neuroplasticity, it is important to note that other adrenal

129
hormones may be involved. Surgical adrenalectomy prevents the release of all
adrenal hormones, not just corticosterone, and these other hormones may be
involved in the behaviors seen following LgA cocaine exposure. Previous work has
shown the ability corticosterone in combination with epinephrine to restore
cocaine-induced sensitization that was diminished through ADX (de Jong,
Steenbergen et al. 2009). This work suggests that there may be role for
epinephrine, as well as corticosterone, in the establishment of cocaine-induced
neuroplasticity and further examination is required in order to determine the role of
epinephrine or other adrenal hormones in the results presented here.
The neuroadaptations put in place by excessive cocaine intake may be put in
place through a variety of mechanisms. One potential mechanism is that sustained
elevations of corticosterone may result in neuroplasticity through interactions with
the glucocorticoid receptor (GR). Corticosterone is a substrate for GR and upon
activation GR translocates into the nucleus of the cell and is involved in the
regulation of transcription and translation for a large number of genes (Reul and de
Kloet 1985; Datson, van der Perk et al. 2001; Deroche-Gamonet, Sillaber et al. 2003).
Previous research has demonstrated that mice lacking GR activity within the central
nervous system retain normal function in the periphery, but demonstrate altered
cocaine SA dose-response behavior, but not acquisition behavior, and have blunted
cocaine-induced behavioral sensitization (Deroche-Gamonet, Sillaber et al. 2003).
These results strongly implicate GR involvement in establishing the neuroplasticity
that forms as a result of long-term exposure to cocaine. Enhanced GR activation in
LgA rats may result in alterations in the expression of multiple genes that could be
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involved in the regulation of later reinstatement. Additionally, elevated levels of
corticosterone may increase the inhibition of transporters, including OCT3, and lead
to changes in expression through chronic inhibition. While our results do not show
any decease in OCT3 expression following cocaine exposure, and even show a slight
increase in protein levels, further work will need to be done in order to confirm our
findings and further explore the effect increased OCT3 expression may have.
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GENERAL DISCUSSION
SUMMARY OF FINDINGS
Chapter 1:
Exposure to electric footshock prior to systemic administration of a
subthreshold, non-reinstating dose of cocaine (2.5 mg/kg, i.p.) results in
reinstatement of cocaine seeking. This effect is blocked in animals that have
undergone adrenalectomy, which indicates the behavior requires stress-induced
increases in corticosterone. The effects of electric footshock on reinstatement are
mimicked by systemic administration of stress levels of corticosterone prior to
administration of the subthreshold dose of cocaine. The corticosterone effect is not
blocked by administration of the glucocorticoid receptor antagonist, RU38486,
suggesting corticosterone is acting through a glucocorticoid receptor-independent
mechanism.
Chapter 2:
Administration of corticosterone directly into either the NAc or PFC prior to
administration of a subthreshold dose of cocaine (2.5 mg/kg, i.p.) results in
reinstatement not seen with administration of cocaine alone at this dose. Systemic
administration of stress level corticosterone prior to administration of a low dose of
cocaine enhances cocaine-induced increases in extracellular dopamine
concentrations in the NAc. Administration of the dopamine antagonist fluphenazine
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into the NAc or PFC blocks the corticosterone-induced potentiation of cocaineinduced reinstatement.
Chapter 3:
The monoamine transporter organic cation transporter 3 (OCT3) is expressed
within the NAc in close proximity to neurons expressing tyrosine hydroxylase,
suggesting an interaction with dopamine. Systemic administration of the OCT3
inhibitor, normetanephrine, prior to an injection of low dose cocaine (2.5 mg/kg,
i.p.) results in reinstatement similar to that seen with electric footshock or stress
level corticosterone.
Chapter 4:
Long access cocaine self-administration (LgA SA) results in an escalation of
drug intake throughout the period of SA that is not seen with short access (ShA) SA.
During LgA SA sessions, plasma corticosterone levels are elevated for a prolonged
period of time compared to ShA SA sessions. Exposure to electric footshock results
in the reinstatement of drug seeking in rats exposed to LgA SA, but not those with
ShA SA. LgA SA also enhances reinstatement in response to administration of the
stress neuropeptide, CRF. Both of these augmentations to later reinstatement are a
result of corticosterone-induced neuroplasticity as neither effect is observed in
animals adrenalectomized prior to the start of SA. A change in OCT3 expression
following LgA SA does not appear to be one of the LgA SA-induced neuroadaptations
occurring.
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DISCUSSION
The chronic relapsing nature of addiction remains the most difficult aspects
of the disease to treat and there is no current, effective treatment available. The
work presented here was designed to examine the role of stress in relapse as
measured using the reinstatement approach. Studies in human addicts have
suggested that there is a strong connection between stressful life experiences and
the likelihood of relapse (Kosten, Rounsaville et al. 1986; Brown, Vik et al. 1995)
and that exposure to acute stress can increase drug cravings (Sinha, Catapano et al.
1999). Extensive work has been done examining the role of stress in reinstatement
using animal models, however the exact mechanisms through which stress can alter
behavior in a rapid time course remains poorly understood. The work presented
here proposes a novel mechanism through which stress can impact reinstatement
behavior through a rapid, nongenomic process.
The results of the experiments performed here provide evidence that
corticosterone released in response to exposure to a stressor can increase the
vulnerability to cocaine seeking upon subsequent exposure to other triggers for
reinstatement. This suggests that stress can act as a stage setter and potentiate the
reinstating properties of other stimuli. While the role of stress in reinstatement is a
heavily studied subject, its ability to act as a stage setter and influence the effects of
other stimuli has not been thoroughly examined. Here we propose that stress is
capable of altering dopamine concentrations through corticosterone-induced
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inhibition of the monoamine transporter, organic cation transporter 3 (OCT3).
While further work is required in order to gain a better understanding of this
system, this may represent a novel mechanism through which stress can influence
the reinstatement of cocaine seeking behavior.
Previous work done in other models has demonstrated the ability of a
stressor, such as electric footshock (EFS), to potentiate cue- or context-induced
reinstatement (Liu and Weiss 2002; Buffalari and See 2009). In these studies,
exposure to footshock stress prior to the introduction of a previously cocaineassociated cue, potentiated reinstatement to either alcohol or cocaine. We have
shown in chapter 1 that exposure to EFS potentiates cocaine-induced reinstatement.
This occurs through a glucocorticoid-dependent mechanism, as the effect is lost in
animals receiving an adrenalectomy prior to reinstatement testing. The role of
glucocorticoids in this reinstatement behavior, however, does not appear to rely on
activation of the glucocorticoid receptor (GR). Activation of GR results in the
alteration of transcription factor activity and can, therefore, influence the
expression of a large number of genes, and therefore potentially alter behavior
(Datson, van der Perk et al. 2001; Deroche-Gamonet, Sillaber et al. 2003). However,
these studies demonstrate the effect of stress level corticosterone, a glucocorticoid
that interacts with GR, on cocaine-induced reinstatement was not blocked following
administration of the GR antagonist RU38486 suggesting that corticosterone is
acting independently of GR activation.
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This suggests that stress may act to increase the response to other appetitive
stimuli. This allows for stimuli that would not normally result in reinstatement,
such as a low dose of cocaine that does not cause reinstatement when administered
alone, to do so when encountered following exposure to a stressor or when
corticosterone levels are elevated. The stress itself does not result in reinstatement
of cocaine seeking under our conditions, as exposure to electric footshock or
administration of corticosterone alone did not result in reinstatement in the model
used here, but rather acts to enhance the salience of other stimuli.
As has been previously demonstrated, stress influences behavior differently
following different levels of cocaine exposure. Exposure to EFS results in
reinstatement in rats with a history of LgA SA, but does not produce this effect in
rats with a history of ShA SA (Mantsch, Baker et al. 2008), an effect that is
dependent upon LgA SA-induced prolonged elevations in corticosterone (Mantsch,
Baker et al. 2008). These findings led us to examine the role of stress in animals
with a history of ShA SA and what effect it may have on reinstatement.
Interestingly, these findings demonstrate a role of corticosterone in rats a history of
ShA SA, not in stress-induced reinstatement, but rather acting as a stage-setter
observed as a potentiation of cocaine-induced reinstatement. Our findings in
chapter 4 show that elevations in corticosterone is not needed at the time of EFSinduced reinstatement in LgA rats, while the work in chapter 1 shows that
corticosterone is required for the potentiation of as cocaine-induced reinstatement
by the same stressor in ShA rats. This discrepancy may involve the different
circuitry involved in the two forms of reinstatement. Cocaine-induced
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reinstatement involves activity within the VTA-PFC-NAc core and ventral palidum,
while stress-induced reinstatement involves the activation of this circuitry along
with the central extended amygdala (McFarland and Kalivas 2001; McFarland,
Davidge et al. 2004). Additionally, stress-induced reinstatement involves a
mechanism that includes the activity of CRF (Erb, Shaham et al. 1998; Graf, Hoks et
al. 2011) that is not required for cocaine-induced reinstatement. In these studies,
administration of CRF antagonists block stress-induced reinstatement, while having
no effect on reinstatement in response to a cocaine-primer. The differing
mechanisms and activated circuitry might allow for corticosterone to play a
different role in two forms of reinstatement.
Another explanation for the lack of a requirement for elevated corticosterone
in EFS-induced reinstatement in rats with a history of LgA SA may be cocaine
intake-dependent neuroplasticity. The augmentation of later reinstatement in
response to stressors (Mantsch, Baker et al. 2008), cues (Kippin, Fuchs et al. 2006),
or administration of a cocaine primer (Mantsch, Yuferov et al. 2004; Knackstedt and
Kalivas 2007; Mantsch, Baker et al. 2008) compared to ShA rats suggests the
induction of neuroadaptations in these LgA rats. The cocaine-induced changes that
occur during LgA SA may alter the contribution of corticosterone during
reinstatement, however, the mechanism through which this occurs needs further
examination.
The effects of corticosterone on potentiation of later reinstatement in ShA
rats appears to involve an increase in dopaminergic activity within the NAc and PFC.
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This is based on results showing that systemically administered corticosterone
potentiates the cocaine-induced increase in NAc dopamine. Further support for
dopaminergic activity within the brain is demonstrated by site-specific
administration of corticosterone into these regions that potentiates cocaine-induced
reinstatement through a mechanism that requires the activation of dopamine
receptors, as this behavior can be blocked with dopamine antagonists (chapter 2).
Both of these regions have been extensively studies in addiction and reinstatement
and it has been demonstrated that dopamine activity within these structures plays a
key role in reinstatement. Inactivation of the PFC by administration of GABA
agonists blocks cocaine-primed reinstatement (McFarland and Kalivas 2001), while
administration of dopamine or dopamine agonists directly into the NAc or PFC
reinstates drug seeking (Wise, Murray et al. 1990; Self, Barnhart et al. 1996; Cornish
and Kalivas 2000; McFarland and Kalivas 2001) and administration of dopamine
antagonists into the NAc shell blocks cocaine-primed reinstatement (Bari and Pierce
2005). Systemic administration of dopamine antagonists has also been shown to
prevent psychostimulant-induced reinstatement (De Vries, Schoffelmeer et al.
1999). This data strongly implicates a role of dopamine in the reinstatement of
cocaine-seeking behavior. We have demonstrated that administration of
corticosterone directly into the NAc or PFC potentiates cocaine-induced
reinstatement. Our results also show that corticosterone potentiates the dopamine
response to cocaine by increasing extracellular dopamine in the NAc following
systemic administration of corticosterone and a low dose of cocaine. Furthermore,
blockade of dopamine activity in either the NAc or PFC through administration of
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the dopamine antagonist, fluphenazine, blocks corticosterone-induced potentiation
of drug-primed. These findings indicate an action of corticosterone within these
brain regions that works to increase dopamine concentration and signaling to
facilitate reinstatement. We have not, however, examined other brain regions in
order to determine if corticosterone is acting system-wide or if the actions are
limited to these specific regions. Further work will need to be done, as it is possible
that corticosterone exerts effects on monoamine levels more broadly in the brain.
Chronic activation of dopamine receptors could influence behavior through
the downstream effects of dopamine receptor activation. Dopamine receptors
influence the activity of adenylyl cyclase and cAMP accumulation, increasing or
decreasing activity depending on the dopamine receptor activated, thereby altering
the signal transduction within the cell (Monsma, Mahan et al. 1990; Cohen, Todd et
al. 1992). Activation of dopamine receptors can also impact cell signaling through
modulation of intracellular calcium stores (Undie and Friedman 1990), potassium
currents (Kitai and Surmeier 1993), arachidonic acid release (Keefe and Gerfen
1995) and Na+-K+-ATPase (Bertorello, Hopfield et al. 1990). Additionally, chronic
elevations in dopamine levels can influence gene expression, including that of
immediate early genes and neuropeptides (Missale, Nash et al. 1998). These data
indicate that alterations in dopamine levels, as would be seen with decreased
dopamine clearance, may have profound impacts on cellular signaling and gene
expression, which would impact behavior.

139
While these findings indicated that stress was capable of influencing cocaineinduced reinstatement through a GR-independent process, the exact mechanism had
yet to be determined. Previous studies indicate that corticosterone is able to
influence dopaminergic activity in the brain. Dopamine neurons express
corticosteroid receptors (Harfstrand, Fuxe et al. 1986) and it has been
demonstrated that a number dopamine-mediated behaviors are facilitated by
glucocorticoids, including the psychomotor effects of drugs (Marinelli, Piazza et al.
1994; Piazza, Rouge-Pont et al. 1996), and that high levels of glucocorticoids and
activation of glucocorticoid receptors are involved in the regulation of stress-evoked
dopamine concentrations (Gilad, Rabey et al. 1987; Butts, Weinberg et al. 2011).
Also, administration of metyrapone, which blocks the synthesis of corticosterone,
prevents stress-induced elevations in dopamine concentrations (Rouge-Pont,
Marinelli et al. 1995). Together, these data suggest an interaction between
corticosterone and dopaminergic activity that may involve glucocorticoid regulation
of clearance.
In order to gain a better understanding of the mechanisms underlying this
interaction, we examined the role of the corticosterone sensitive, monoamine
transporter, OCT3. OCT3 is expressed throughout the brain, including the NAc as
demonstrated in chapter 3 (Gasser, Orchinik et al. 2009)and is expressed in close
proximity to tyrosine hydroxylase (TH) positive neurons in the NAc, suggesting it is
very likely to be an active dopamine transporter within this region. To examine the
role of OCT3 in the corticosterone-dependent reinstatement behavior we have
shown in earlier experiments, we tested the ability of the OCT3 inhibitor,
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normetanephrine, to influence reinstatement. Administration of normetanephrine
prior to an injection of low dose cocaine resulted in reinstatement similar to that
seen following exposure to a stressor or administration of corticosterone. As OCT3
is an uptake2 transporter capable of transporting dopamine and can be directly
inhibited by corticosterone (Grundemann, Schechinger et al. 1998), this represents
a viable mechanism through which stress can influence dopamine concentrations
and alter behavior.
The exact localization of OCT3 is not yet fully understood. While it is shown
to be expressed at varying levels throughout the brain (Gasser, Orchinik et al. 2009),
the exact cell type and location on those cells has yet to be determined. Localization
on astrocytes could position OCT3 to regulate monoamine levels across a large
number of synapses and be involved in controlling the spread to other synapses.
Further staining studies will have to be done in order to determine co-localization
with astrocytic or neuronal markers, as well as markers identifying pre-or postsynaptic localization.
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Figure 21. Model of OCT3-mediated regulation of monoamine clearance. Red=
Dopamine, Blue= Dopamine transporter, Green= OCT3.

We propose that following exposure to a stressor, elevated corticosterone
levels result in the inhibition of OCT3. This results in the loss of uptake2-mediated
dopamine clearance and sets the stage for other stimuli to greatly influence
behavior. Any stimulus, such as acute exposure to a drug such as cocaine that
inhibits DAT, could elevate dopamine levels to a point where the primary
transporters (DAT) are saturated and without the activity of OCT3, dopamine
concentrations may be able to reach levels that result in changes in behavior, such
as relapse. The ability of stress to act as a stage setter and alter the response to
other stimuli may play a role in behaviors beyond those seen in addiction and may
be involved in coping mechanisms during periods of stress. Activity in the
mesolimbic dopamine system, which includes dopamine projections from the VTA
to the PFC, NAc, amygdala and BNST (Pierce and Kumaresan 2006), has been shown
to play a role in motivated behavior, including incentive motivation (Wise, Spindler
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et al. 1978; Gerber, Sing et al. 1981; Stewart, de Wit et al. 1984), as well as
responding to negative stimuli (Matsumoto and Hikosaka 2009). This suggests that
during periods of stress and blockade of OCT3, the response to any salient stimulus
may be exaggerated, which could aid in any survival situation by further reinforcing
the positive or negative value assigned to a situation or environment. As
corticosterone appears to have no effect of its own, only the potential coping or
safety mechanisms receive enhanced value. This may represent a mechanism
through which stress can influence behavior in a rapid, non GR-dependent manner
and further demonstrates the importance of the body’s stress response to an
animal’s survival.
Our findings represent a novel mechanism through which corticosterone can
influence reinstatement behavior on a rapid time scale, independent of GR
activation. Previous work has demonstrated the role of persistant GR activation in
increasing the rewarding properties and enhancing the motivation for cocaine
(Deroche, Marinelli et al. 1997; Deroche-Gamonet, Sillaber et al. 2003). These
studies demonstrated that adrenalectomy significantly shifts the cocaine dose
response curve downward and this effect can be reversed with administration of
corticosterone. It was also demonstrated that antagonism of GR produces a similar
decrease in motivation for cocaine. The data presented here, however, show a rapid
effect of corticosterone that exerts effects on behavior in a time course not
consistent with activation of GR and the effects we have shown are not blocked with
the use of RU38486. These results demonstrate the ability of corticosterone to
rapidly influence behavior, potentially through its interaction with OCT3, an
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important finding considering the lack of research done on the acute effects of stress
and the impact it has on behavioral processes.
In addition to influencing acute susceptibility to reinstatement, elevated
glucocorticoids at the time of drug use appear to be critical for the establishment of
addiction-related neuroplasticity. In humans this likely contributes to a loss of
control over their ability regulate drug use and increases long-term susceptibility to
relapse. Evidence suggests that humans who use cocaine with greater frequency
show greater craving and relapse potential than those who use less frequently (Fox,
Talih et al. 2005). In rats, this effect can be studied using the LgA SA approach. Like
stressors, cocaine activates the HPA axis (Kuhn and Little 1995), and LgA SA
prolongs this activity as a result of the longer periods of cocaine exposure (Mantsch,
Yuferov et al. 2003; Mantsch and Katz 2007; Graf, Hoks et al. 2011). The
pronounced HPA axis response in LgA rats compared to ShA rats, suggests that
many of the addiction phenotypes that arise, such as augmented reinstatement
sensitivity and escalation of drug use, may require glucocorticoid activity. This is
supported by the studies we have performed demonstrating the need for cocaineinduced corticosterone elevations in the establishment of increased susceptibility to
later stress- and CRF-induced reinstatement (Mantsch, Baker et al. 2008; Graf, Hoks
et al. 2011). The exact mechanism through which corticosterone establishes this
plasticity is not clear, but likely requires other stress and cocaine-activated systems
as administration of corticosterone alone to ShA rats during SA does not produce
the same effects (unpublished observation). The plasticity seen may involve
glucocorticoid blockade of OCT3 since this is a system that requires activity of
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monoamines in order to exert a behavioral effect, as we expect to see no effect with
OCT3 inhibition alone (as seen in figure 21). Alterations in GR activity may also be
involved as previous work has shown that inactivation of GR within the brain
prevents cocaine-induced behavioral sensitization, another behavior dependent
upon cocaine-induced neuroplasticity (Deroche-Gamonet, Sillaber et al. 2003).
In order to study the intake-dependent alterations in behavior, we examined
reinstatement in rats exposed to either short access (ShA; 2 hours/day) or long
access (LgA; 6 hours/day) cocaine self-administration (SA). We, and others, have
previously shown that animals with a history of LgA SA escalate their drug use
during the SA period (Ahmed and Koob 1998; Ahmed and Koob 1999; Mantsch, Ho
et al. 2001) and later reinstatement by a number of stimuli, including stressors, is
augmented (Mantsch, Yuferov et al. 2004; Ahmed and Cador 2006; Mantsch, Baker
et al. 2008). We have also shown that animals undergoing LgA SA show prolonged
elevations in plasma corticosterone levels that are required for the intake
dependent alterations in reinstatement to EFS or i.c.v. CRF, the stress neuropeptide
(Graf, Hoks et al. 2011), another example that the prolonged elevations in plasma
corticosterone are required to establish neuroadaptations that allow for the
augmented reinstatement.
We then tested the possibility that changes in Oct3 expression might account
for the heightened relapse seen following LgA cocaine SA. Alterations in OCT3
expression may alter reinstatement behavior in LgA rats as it has been
demonstrated that chronic cocaine exposure results is increases in cocaine-induced
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dopamine concentrations (Henry, Greene et al. 1989; Ackerman and White 1990;
Madayag, Kau et al. 2010). We hypothesized that intake-dependent alterations in
OCT3 expression may render an individual more susceptible to elevations in
dopamine that could lead to the reinstatement of cocaine seeking. In chapter 4 we
examined the expression of OCT3 following ShA and LgA cocaine SA and compared
it to levels seen in drug naïve rats. We proposed that chronic elevation of
corticosterone could decrease OCT3 expression, thus producing a state similar to
that seen following corticosterone-induced inhibition of OCT3, and may represent
one means of neuroplasticity that could alter later reinstatement. This could occur
as the result of chronic corticosterone-induced inhibition of OCT3 or alterations in
OCT3 gene translation that occurred in response to prolonged activation of GR. Our
findings, however, did not show any significant, intake-dependent changes to OCT3
mRNA in either region and only a slight increase in protein in the PFC. While further
research needs to be done in order to confirm these findings, it does not come as a
complete surprise. In order for an organism to maintain its ability to perform well
and adapt to the environment during periods of stress, this system needs to remain
functional. Any alterations in OCT3 expression could negatively affect an organism’s
ability to assign value to salient stimuli and decrease the ability to cope with stress.
While the work presented here strongly implicates the role of OCT3 in the
acute effects of stress, further work needs to be done in order to confirm these
findings. The pharmacological inhibitors of OCT3 used in these experiments,
corticosterone and normetanephrine, have actions in addition to their ability to
block OCT3-mediated clearance. Corticosterone interacts with the
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mineralocorticoid receptor (MR) as well as GR, with much higher affinity for MR
than GR (Reul and de Kloet 1985). The lack of an effect following administration of
the GR antagonist, RU38486, suggests that GR does not play a role in the behavior
we have seen, however, we have not examined a possible role for MR. The affinity of
MR for corticosterone, however, would suggest that MR is bound by corticosterone
even under basal conditions, allowing for no additional binding during periods of
stress (de Kloet, Joels et al. 2005).
Additionally, normetanephrine has actions beyond inhibition of OCT3 that
may influence reinstatement. It has been reported that normetanephrine is capable
of acting as a weak agonist at -adrenergic receptors (Langer and Rubio 1973), an
action that could alter cocaine seeking itself (Lee, Tiefenbacher et al. 2004;
Feltenstein and See 2006) through activation of central noradrenergic
neurotransmission. While this is a concern that may need to be addressed in the
future in order to confirm the role of OCT3, it is believed that the dose of
normetanephrine used in these experiments would lead to a very low level of
interaction with the -adrenergic receptors compared to OCT3.
Because of the lack of specific, selective inhibitors of OCT3, in order to better
examine the exact role of OCT3 in the behaviors seen here, an animal knockout or
knockdown model will ultimately be necessary. The use of an adeno-associated
virus (AAV) to temporarily knockdown the expression of OCT3 could be a useful
tool for studying its role in reinstatement. If able to successfully knockdown OCT3
levels prior to reinstatement testing we would be able to determine if there are
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other factors involved in the effects we have seen. If animals with decreased OCT3
functionality at the time of reinstatement testing reinstate to the subthreshold dose
of cocaine (2.5 mg/kg, i.p.) used in chapter 1 alone, it would further support OCT3 as
the mechanism responsible. If, however, corticosterone were still able to potentiate
the reinstating effects of cocaine, it would suggest that other factors are involved in
this process. Furthermore, the use of the OCT3 knockout mouse (Zwart, Verhaagh
et al. 2001) could be beneficial in learning more about the behavior of an animal
lacking this transporter, including the role of the -adrenergic receptor, a issue that
needs to be addressed in the studies using normetanephrine as an OCT3 inhibitor.
This model would present a variety of other variables that would need to be
considered prior to testing, however. As the knockout model currently only exists in
mice, experimentation would involve a change in the species being studied. This
may alter the experimental paradigms we are able to use and may impact the results
found. Additionally, work would need to be done in order to examine the behavioral
phenotype of mice lacking OCT3 expression throughout development. This may
play a role in many behavioral processes, including the animals stress response
system and could influence the results of the studies.
An additional area that needs to be further examined involves the exact
mechanism through which dopamine concentrations are elevated following
administration of corticosterone and cocaine, as seen in chapter 2 with the in vivo
microdialysis experiments. While we propose that corticosterone-induced blockade
of OCT3-mediated dopamine clearance accounts for the elevation in dopamine
concentrations, we have yet to directly show a role for clearance in this process.
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While previous work has suggested a role of glucocorticoids in alterations in the
clearance of dopamine (Gilad, Rabey et al. 1987), the exact mechanism of dopamine
alterations needs to be confirmed. Studies demonstrating the presence of GR on
mesocorticolimbic dopamine cells suggests a potential for glucocorticoids to alter
dopaminergic neurotransmission independent of changes in clearance (Harfstrand,
Fuxe et al. 1986). In vivo microdialysis is useful in measuring the concentrations of
dopamine over a period of time, it is not capable of differentiating between changes
in release or alterations in clearance. The use of fast scan cyclic voltametry (FSCV)
would aid in gaining a better understanding of this process. This technique would
allow us to examine the clearance of dopamine under various treatment conditions
on a very rapid time scale. The ability to demonstrate a decrease in dopamine
clearance that is enhanced by corticosterone or normetanephrine would strongly
implicate the role for a transporter and add further support for OCT3 being involved
in the mechanism proposed here.
Furthermore, studies will need to be performed that examine the role of
other monoamine neurotransmitters. Since cocaine is a nonspecific monoamine
uptake inhibitor (Glowinski and Axelrod 1965; Iversen 1973; Rothman, Baumann et
al. 2001) and OCT3 is involved in the clearance of norepinephrine, serotonin and
histamine as well as dopamine (Grundemann, Schechinger et al. 1998; Grundemann,
Liebich et al. 1999), other neurotransmitters will need to be examined, however, we
have demonstrated a role for dopamine as systemic corticosterone effects were
blocked by site specific fluphenazine administration. As previously stated, studies
have demonstrated a role of noradrenergic activity in reinstatement (Erb, Hitchcott
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et al. 2000; Lee, Tiefenbacher et al. 2004; Shepard, Bossert et al. 2004).
Additionally, elevations of serotonin have been shown to have rewarding properties
(Filip, Frankowska et al. 2005) and inhibition of the 5-HT2A receptor, or stimulation
of the 5-HT2C receptor have been shown to attenuate cocaine- and cue-induced
reinstatement (Grottick, Corrigall et al. 2001; Fletcher, Grottick et al. 2002;
Neisewander and Acosta 2007). In order to gain a better understanding of the
mechanism behind corticosterone-induced potentiation of reinstatement, other
neurotransmitters will need to be examined, as dopamine may not be the only
monoamine affected through inhibition of OCT3.
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CONCLUSIONS
The results from these experiments provide pre-clinical evidence that stress
can act as a stage setter in making animals more likely to engage in compulsive
cocaine seeking when exposed to a stimulus that would otherwise not elicit such a
reaction. We believe that this effect involves inhibition of the monoamine
transporter, OCT3, by corticosterone, leading to decreased dopamine clearance
within brain regions involved in drug seeking. Overall, these data suggest that
influencing the ability of OCT3 to regulate monoamine levels may represent an
approach for treating relapse during periods of stress and may lead to an
improvement in the treatment strategies aimed at managing cocaine addiction.
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